WO2005029705A2 - Number coding for identification of subtypes of coded types of solid phase carriers - Google Patents
Number coding for identification of subtypes of coded types of solid phase carriers Download PDFInfo
- Publication number
- WO2005029705A2 WO2005029705A2 PCT/US2004/030499 US2004030499W WO2005029705A2 WO 2005029705 A2 WO2005029705 A2 WO 2005029705A2 US 2004030499 W US2004030499 W US 2004030499W WO 2005029705 A2 WO2005029705 A2 WO 2005029705A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carriers
- particles
- sample
- different
- displaying
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Definitions
- the molecular analysis of multiple analytes is performed in accordance with the Random Encoded Array Detection (READTM) format, as described in U.S. Application Serial No. 10/204,799, filed on 8/23/2002, entitled “Multiaiialyte Molecular Analysis Using Application-Specific Random Particle Arrays” using microparticles ("beads") as the solid phase carriers.
- RTDTM Random Encoded Array Detection
- N small numbers
- the examples relate to small numbers, N, of analytes, where N ranges from 2 to 4.
- the molecular analysis of multiple analytes, and particularly the analysis of nucleic acid sequences generally must accommodate numbers of analytes in the range of tens of analytes, or about 10 ⁇ N ⁇ 100.
- An example is the multiplexed analysis of the 25 mutations in the cystic fibrosis transmembrane regulator gene designated by the American College of Medical Genetics (ACMG) for pan-ethnic carrier screening, requiring at least 25 pairs of probes to discriminate nonnal and variant alleles.
- ACMG American College of Medical Genetics
- each ⁇ ik is bounded from below as a result of placing confidence intervals on assay scores.
- the random encoded array (READTM) format or equivalent assay formats requires minimal multiplicities in the range of 30-50 to ensure desirable confidence intervals on assay determinations.
- N-coding number coding
- N-coding permits the representation of a finite number of known or anticipated assay scores or outcomes for each of a multiplicity of types of probes or receptors included in the analysis.
- N-coding thus can be used to discriminate nucleic acid alleles by N-coded subtypes of carriers, each subtype displaying a probe matched to one of the known or anticipated alleles; specifically, N-coding can be used to discriminate normal and variant alleles by pairs of probes, one of these complementary to the normal ("wildtype", W) allele and represented by a multiplicity m , the other complementary to the variant ("V") allele and represented by a multiplicity my, where my ⁇ m but both alleles share one color code.
- N-coding also can be used to discriminate epitopes by N- coded subtypes of carriers, each subtype displaying a receptor capable of binding to one of the known or anticipated epitopes of a ligand of interest, all such epitopes or ligands sharing one color code.
- N-coding of pairs ("doublets") or small sets ("multiplets") of solid phase carriers provides distinguishable subtypes of a given type of such carriers, where each carrier type is distinguishable on the basis of a C-code. Such number coding is useful for augmenting a coding system, such as a color code, and thereby effectively multiplying the number of "colors" (distinguishable sub-types).
- members of a pair of probes are encoded by N-coding of solid phase carriers of the same color, but each of several such different pairs of probes will be associated with a carrier type of a different color.
- This embodiment is useful, for example, in multiplexed mutation analysis, where a color code can be augmented (effectively doubled) by N-coding carriers displaying pairs of probes, where the pair members are complementary to, respectively, a wild-type and variant allele.
- sets of probes complementary, for example, to a polymorphic region and to each of the four possible bases at a designated polymorphic position within the region are encoded by N-coding of solid phase carriers of the same color, and each of several such different sets of probes will be associated with a carrier type of a different color.
- proteins (peptides) representing epitopes can be associated with a solid phase carrier and used to screen biological samples for reactive proteins or antibodies.
- the C-coding can be augmented by N-coding of solid phase carriers of the same color, where such a carrier subset carries the pairs or set of proteins conesponding to such pairs or sets of epitopes, as applicable.
- the solid phase carriers preferably are microparticles which are assembled into planar arrays of particles on a substrate for use in the Random Encoded Array Detection
- FIG. 1A to 1 ID show assay results of numerical coding for detecting the F508 mutation using elongation detection, in the form of a series of four histograms, where, in each histogram, the number of beads displaying a signal of a certain intensity is plotted against intensity.
- FIG. 2 depicts the native conformation of a protein which can be bound to either of two antibodies; the generation of synthetic peptide fragments corresponding to different linear epitopes of the protein and attaching the fragments to beads; and, the binding of labeled antibodies to the peptide fragments on the beads.
- a labeled secondary antibody could be used for detection, if the peptide fragments were initially bound by an unlabeled antibody (not shown).
- Fig. 1A to 1 ID show assay results of numerical coding for detecting the F508 mutation using elongation detection, in the form of a series of four histograms, where, in each histogram, the number of beads displaying a signal of a certain intensity is plot
- FIG. 3 depicts a coding system with four different C-codes ("colors") to encode bead types, for use in detecting antibodies against eight different peptides (PI to P8).
- Fig. 4 depicts a histogram showing the number of beads displaying a certain intensity as a function of intensity, for detection of the "V" and "W” alleles using different numbers of carriers displaying probes which bind to the V or the W alleles. In the preferred case, the histogram has two distinct, non-overlapping peaks.
- Fig. 5 depicts a plot of results as show in Fig. 4, but for overlapping histogram peaks in this case.
- FIG. 6 is a histogram representing the probability of selecting a given number of carriers ("beads") of particular types of 70 subtypes, based on the evaluation of 40 random encoded arrays of beads, where the anticipated number of beads of each type was about 60. A total of about 3,500 beads (of 70 types) are anticipated to be present in each of the 40 bead arrays, based on an average 90% occupation of available sites. For each type, the CV was calculated over the population of 40 arrays evaluated.
- Fig. 7 is a histogram plot as in Fig. 6, but for another type of beads.
- Fig. 8 is a plot of confidence interval against number of beads, at different CVs and significance levels ( ⁇ ). Fig.
- nc W and nc V are selected so as to differ by a quantity ⁇ nc, which is sufficiently large to ensure that an unambiguous call can be made in view of the practical considerations and requirements discussed above.
- the selection criterion for nc W and nc V is discussed in greater detail below.
- Each pair of probes can encounter only three possible scenarios: the W allele, the V allele or a heterozygous (H) target.
- each different set of probes would carry, at the 3' terminal probe position juxtaposed to the SNP site, one of four different nucleotides: A, C, G or T.
- Each set of probes would be attached to a carrier to form a carrier subtype, and there would be different numbers of each such subtype. The possible outcomes in such case would multiply to one positive for each of a possible four, or any combination of two positives for heterozygotes.
- N-coding also could be used in assays for detecting the presence, in a sample, of antibodies capable of binding to peptides displayed on beads, or, in the reverse situation, for detecting peptides in a sample where the antibodies are displayed on beads.
- N-coding could be used for increasing the number of available codes, where, for example, color coding is used to discriminate among peptide-antibody combinations. That is, certain combinations can be encoded using carriers of the same color, by N- coding of such same-colored carriers to discriminate among such different combinations.
- An assay for detecting antibodies can be of particular utility for detecting auto-antibodies in a patient, in support of a diagnosis of autoimmune disease.
- N-coding is useful when beads of a single color 'are employed, but are functionalized to display three different peptides to detect antibodies in a sample directed against one or more of the peptides, each peptide representing one specific epitope of the cognate antigen.
- Different numbers of beads displaying each of the three peptides would be pooled; i.e., X beads display peptide PI, Y beads display peptide P2, and Z display peptide P3.
- the pooled beads are then placed in contact with a sample which may contain antibodies against one or more of the peptides PI, P2 or P3.
- the sample is removed, and the beads are exposed to a labeled, secondary detection antibody which binds to any antibodies bound to the peptides on the beads (e.g., a goat anti-human antibody, if the sample is human); the assay signals are then recorded.
- the assay would have been first calibrated so that differences in relative signal can be correlated with numbers of labeled beads; i.e., one would be able to determine, based on the relative signal, whether X, Y, Z or a combination or sub-combination of X, Y and Z beads generated a signal, indicating they had bound to antibodies in the sample.
- the N-coding design in Table 2A may be used.
- Decoding the signal therefore, indicates which specificepitope (or epitopes, if the signal indicates that a combination or subcombination of X, Y and Z beads generated a signal) were recognized by antibodies in the sample. This will permit classification of autoantibodies into subtypes for each autoantigen. This assay system would be adequate where one was detecting relatively small numbers of different antibodies, and using numbers of beads where X, Y and Z are widely different. As noted above, N, the total number of beads, must have a unique decomposition, and the larger the numbers of peptides PI ...Px, the more difficult it is to construct such a unique decomposition.
- This assay system could also be used where a population of beads has uniquely encoded (e.g., C-coded) populations, N-coding can be enhanced to distinguish among a number of particles exceeding the number of available C-codes.
- C-coded bead populations are each associated with, respectively, proteins or peptides PI, P2, P3 and P4, and members of each bead type also are associated with proteins or peptides P5, P6, P7 and P8.
- the t-distribution provides an expression relating the values (w, Overline ⁇ I w ⁇ , S w 2 ) and (v, Overline ⁇ I v ⁇ , S v 2 ) to the desired probabilities that confidence intervals constructed from the two sets of observations and placed on the mean values of the observed intensities contain the true mean values ⁇ Iw > and ⁇ Iy >.
- the t-distribution can be applied in this circumstance to test whether the means of the two intensity populations are the same (or not) (see e.g, Chapt. 9 in "Principles of Statistics", M. G. Buhner, Dover Publications, 1979, incorporated by reference).
- H ELSE find an optimal threshold, T, such that:
- n+(T) andn-( ⁇ ) are obtained by integration over the two partitions produced by partitioning of the histogram in accordance with the selection of the threshold T.
- T extreme values of the threshold, T, either to the right extreme of the overlap region or to the left extreme of the overlap region will produce the greatest deviations in n and p (Fig. 5).
- N-coding is preferably used only when it can be ensured that the N-coded subtypes produce substantially different assay signal intensities, thereby minimizing peak overlap . That is, N-coding in accordance with the present invention preferably is used to represent discrete outcomes of an assay such that overlap between partitions in an intensity histogram is negligible.
- N-coding to represent assay outcomes only when the observed mean assay signal intensities are separated by at least one standard deviation, and preferably three standard deviations, to minimize the maximal number of possible false negatives or false positives.
- w and v must be chosen in accordance with a design criterion such as the one stated above.
- Number Fluctuations - h addition to accounting for experimental uncertainty in the determination of the values of p and n, allowance also must be made for statistical uncertainty regarding the values w and v themselves. Such uncertainty can arise as a result of fluctuations in the number of particles contained in aliquots (of nominally identical volume) that are prepared in the course of practicing the invention.
- N-coding is then particularly useful in connection with a color code ("C-code") because it reduces the set of color codes required for encoding of a given number of probes. For example, for the ACMG panel of 25 CF mutations requiring, instead of 50 color codes, only 25 color codes are required. Conversely, N- coding extends by a factor of two the coding complexity of a given set of color codes, thereby facilitating the process of manufacturing sets of color-encoded particles. Therefore, provided that N codes are constructed in accordance with the design rules outlined above, N coding can be used as part of a coding system involving color or other encoding markers, for certain of the carriers in a larger group, where such carriers are encoded identically but for their number codes.
- EXAMPLE 1 N-Coding of eMAP Probes for Detection of ⁇ F 508 CF Mutation Mutation analysis was performed by placing members of a probe pair, designed to detect wild type and the ⁇ F 508 cystic fibrosis ("CF") mutation on beads of the same color, but selecting different numbers of V-beads and W-beads. Ass ay results were analyzed by recording signal intensities indicating hybridization of probe and target, and by analyzing these results in accordance with the histogram representation and CCC procedure described herein.
- CF cystic fibrosis
- the ratio of W:V was 1:5, and on a second chip the ratio of W:V was 5:1.
- eMAP elongation assay
- Known wild type and ⁇ F 508 heterozygous samples were applied to both types of chips, and histograms were generated. See Figs. 1A to ID.
- BEAD FUNCTIONALIZATION Aliquots of a suspension of a bead designated G3H (a blue-green tosylated bead modified with Bovine Serum Albumin ("BSA") in accordance with the methods disclosed in a co-pending application was functionalized with each of the following amino-modified DNA probes: 508W: Sequence: GGC ACC ATT AAA GAA AAT ATC ATC (SEQ ID NO. 1) ⁇ F 508: Sequence: GGC ACC ATT AAA GAA AAT ATC ATT (SEQ ID NO. 2) The following protocol was used to attach these probes to the BSA-modified beads.
- BSA Protocol 1. Add lOO ⁇ L of beads to a tube containing 500 ⁇ L PBST, mix with vortex 2.
- ASSEMBLYOFRANDOMENCODEDBEADARRAYS A total of four arrays were assembled on the upper surface of a substrate (a "chip"), where two of these arrays were composed of Pool A, and the other two were composed of Pool B.
- ELONGATION ASSAY For the elongation, 6.5 ⁇ L PCR product was extracted from known WT or M samples and placed into a PCR tube, to which 2 ⁇ L Exo-sap was added. The mixture was incubated at 37°C for 25 min and 80°C for 15 min (in a thermocycler). Thereafter, ⁇ exonuclease was used for digestion into single stranded DNA.
- the reaction mixture included each of: dGTP, dTTP , dATP and dCTP.
- Ex- 10 primers were used in multiplexed PCR: SEQ ID NO. 3: GGC GTC CCA AAA GGG TCA GTG AGC CTT CAG AGG , GTA AAA T SEQ ID NO. 4: GCG GTC CCA AAA GGG TCA GTC AGT AGC TTA CCC ATA GAG G
- SEQ ID NO. 4 GCG GTC CCA AAA GGG TCA GTC AGT AGC TTA CCC ATA GAG G
- Figs. 1 A to ID in the form of a series of four histograms. In each histogram, the number of beads displaying a signal of a certain intensity is plotted against intensity. In Fig.
- a wild-type (“W”) sample is added to a bead pool in which the ratio of the number of beads functionalized with probes complementary to the W subsequence to that of beads functionalized with probes complementary to the variant ("V") is 1 to 5.
- the histogram has two peaks, but, as expected, the peak corresponding to the beads producing a positive signal has only a small area, indicating that only a small number of beads produce a positive signal.
- the sample is the same, but the ratio of beads of each type is reversed, and, as expected, the reverse ratio of peak areas is observed in the histogram.
- Fig. IB the sample is the same, but the ratio of beads of each type is reversed, and, as expected, the reverse ratio of peak areas is observed in the histogram.
- Example 2 - Detecting Auto-antibodies
- Table 1 Fig. 9
- three synthetic peptides P6, P8, and P12 are affixed to the same colored microspheres in separate reactions. These synthetic peptides are biotinylated at their N-termini with an 18-carbon spacer and immobilized by way of biotin-neutravidin complex formation.
- Beads are pooled, for example, at ratios of one part of P6-functionalized beads, two parts of P8- functionalized beads, and four parts of PI 2- functionalized beads and an array is assembled on the surface of a silicon chip (BeadchipTM). Beadchips were incubated in separate experiments with two 1:20 diluted serum samples positive for antibody directed against a lupus characteristic antigen, SCL-70 (#1764 from BiosPacific and #68933 from METIC Lab. After removing non-reacted antibodies, specific antibodies captured by the peptides were visualized using a fluorescently labeled goat-anti-human IgG antibody-conjugate.
- Decoding and assay images were acquired using a microscope equipped with a CCD camera, as in the previous example.
- the assay signals were extracted, and the Pi/P7 ratios (peptide-specific signal intensity vs. the signal intensity of negative control peptide, P7) were calculated. Beads with an intensity value significantly higher than that of the negative control were designated positive.
- the presence of P6, P8 or P12-specific antibodies was determined by the relative numbers of positive beads. As shown in Table 1 (Fig. 9), assaying sample #1764 yielded 300 positive beads, meaning the positive beads captured anti-P8 (100 positive beads) and anti-P12 (200 positive beads) antibodies.
- Sample #68933 yielded 150 positive beads, meaning the positive beads captured anti-P6 (50 positive beads) and anti-P8 (100 positive beads) antibodies.
- Example 3 Number Fluctuations in Random Encoded Bead Arrays
- 50 ⁇ l aliquots of each bead type are taken from a reservoir containing 1ml of a stable suspension and split in order affix to each particle of a specific type a selected chemical entity such as an oligonucleotide probe.
- 5 ⁇ l aliquots of probe-functionalized beads are taken from each reaction container and pooled to produce 250 ⁇ l of suspension containing 50 types of functionalized beads.
- a 0.5 ⁇ l aliquot of pooled bead suspension is placed onto a planar silicon substrate, covering an area of approximately 1mm which includes a designated area of 300 ⁇ m by 300 ⁇ m, thus approximately 10% of the total area, for assembly of a planar array of 4000.
- bead types will be distributed about the mean value, say the average density of particles in the original volume of suspension, in accordance with a Poisson distribution such as those shown in Figs. 6 and 7.
Abstract
Disclosed is number coding of pairs ('doublets') or small sets ('multiplets') of solid phase carriers provides distinguishable subtypes of a given type of such carriers, where each carrier type is distinguishable on the basis of a C-code. Such number coding is useful for augmenting a coding system, such as a color code, and thereby effectively multiplying the number of 'colors' (distinguishable sub-types). It can be applied, for example, in multiplexed nucleic acid or protein analysis.
Description
Number Coding for Identification of Subtypes of Coded Types of Solid Phase Carriers
RELATED APPLICATIONS This application claims priority to US Provisional Application No. 60/504,294, filed 9/18/2003. FIELD OF THE INVENTION The invention is in the field of encoded carriers for chemical entities. BACKGROUND Solid phase carriers for multiplexed analysis of multiple analytes, preferably are encoded using one of several available color coding methods (see US Serial No. 09/448,420, filed 11/23/99, entitled "Color*Encoding and h -Situ Interrogation of Matrix- Coupled Chemical Compounds"; US Serial No. 10/348,165, filed 1/21/2003, entitled "Method of Controlling Solute Leading of Polymer Microparticles," U.S. Patent No. 4,499,052 "Apparatus for Distinguishing Multiple Subpopulations of Cells) to produce spectrally distinguishable carriers; or using chemical tagging methods such as those commonly employed for encoding of combinatorial libraries to produce carriers distinguishable by way of decoding these tags by one of several methods known in the art (see, e.g., U.S. Patent No. 6,503,759 "Complex Combinatorial Chemical Libraries Encoded with Tags"), hi applications of interest, solid phase carriers are functionalized to display chemical entities such as nucleic acid probes or protein receptors, each such entity being uniquely associated with a code and defining a carrier type. Preferably, the molecular analysis of multiple analytes is performed in accordance with the Random Encoded Array Detection (READ™) format, as described in U.S. Application Serial No. 10/204,799, filed on 8/23/2002, entitled "Multiaiialyte Molecular Analysis Using Application-Specific Random Particle Arrays" using microparticles ("beads") as the solid phase carriers. A method of encoding by providing multiple instances ("multiplicities") of each distinguishable type of carrier within a set of N such types has been described in connection with a flow cytometric multiplexed immunoassay format (See US Patent No. 5,567,627 - Lehnen). Although Lehnen states that larger numbers of analytes may be
analyzed with this method, the examples relate to small numbers, N, of analytes, where N ranges from 2 to 4. However, the molecular analysis of multiple analytes, and particularly the analysis of nucleic acid sequences, generally must accommodate numbers of analytes in the range of tens of analytes, or about 10 <N <100. An example is the multiplexed analysis of the 25 mutations in the cystic fibrosis transmembrane regulator gene designated by the American College of Medical Genetics (ACMG) for pan-ethnic carrier screening, requiring at least 25 pairs of probes to discriminate nonnal and variant alleles. To ensure an unambiguous decoding, application of the method in Lehnen for use in a method of encoding carriers requires a unique decomposition of N into summands, mk, such that no partial sum obtained by adding two or more summands can be obtained in any other way of combining summands, and no summand is itself the sum of two or more of the other summands. For example, if N=10 analytes are to be displayed on uniquely coded carriers, one might select ten prime numbers in an attempt to construct a unique set of multiplicities as required by Lehnen, e.g.: mi = 5, m2 = 7, m3 = 11, m4= 13, m5 = 17, m6 = 19, m7 = 23, m8 = 29, m9 = 31, m10 = 37, only to discover that this prescription fails, even for this value of N = 10, given that mi + IΪLJ = m2 + m3 and other non-unique combinations, which can be seen. Therefore, the task of constructing a unique decomposition for any N represents a problem to which Lehnen does not provide a solution. Additional difficulties arise when consideration is given to practical requirements in assay design. For example, in typical quantitative assays which may produce, for each of several types of constituent probes, signal intensities varying over a wide range, the respective mean signal intensities generally will not be known a priori. Thus, even in the case of only two different types of carriers, when the standard deviation of the assay signal produced by the multiple instances of the first type of probe is comparable to the difference in mean signal intensities of first and second types of probes, codes will be corrupted, decoding will be compromised and assay scores will be indeterminate. Assay signal intensities have been observed to vary by 10% to 30% about the mean over a specific carrier type.
Additional practical requirements place further constraints on practical codes. Thus, each πik is bounded from below as a result of placing confidence intervals on assay scores. As described in greater detail below, this constraint, the random encoded array (READ™) format or equivalent assay formats, requires minimal multiplicities in the range of 30-50 to ensure desirable confidence intervals on assay determinations. Each ni also is bounded from above by the fact that the total number of carriers, M, readily accommodated in a practical assay format and thus typically in the range of -100 to -10,000, is finite, where M = __ (__i) t0 (k = N) m , implying an upper limit for each of the ni . Further, in practice, the number of carriers of any given type contained in aliquots of suspension of nominally equal volumes will display a statistical variation, requiring that values of individual multiplicities be selected so as to differ from one another by at least several standard deviations about each mean, and thus not be spaced too closely. The methods described in Lehnen, therefore, do not enable multianalyte molecular analysis and also are not practical or desirable as a means of carrier encoding. However, when number coding ("N-coding") is augmented by an additional code
- such as chemical coding and specifically color coding ("C-coding") - and when applied to represent a finite, known number of outcomes for each of a multiplicity of probe types included in a multiplexed analysis, it is practical and desirable. In a multiplexed analysis of molecular analytes, N-coding permits the representation of a finite number of known or anticipated assay scores or outcomes for each of a multiplicity of types of probes or receptors included in the analysis. N-coding thus can be used to discriminate nucleic acid alleles by N-coded subtypes of carriers, each subtype displaying a probe matched to one of the known or anticipated alleles; specifically, N-coding can be used to discriminate normal and variant alleles by pairs of probes, one of these complementary to the normal ("wildtype", W) allele and represented by a multiplicity m , the other complementary to the variant ("V") allele and represented by a multiplicity my, where my ≠m but both alleles share one color code. N-coding also can be used to discriminate epitopes by N- coded subtypes of carriers, each subtype displaying a receptor capable of binding to one of the known or anticipated epitopes of a ligand of interest, all such epitopes or ligands sharing one color code.
SUMMARY OF THE INVENTION Number coding of pairs ("doublets") or small sets ("multiplets") of solid phase carriers provides distinguishable subtypes of a given type of such carriers, where each carrier type is distinguishable on the basis of a C-code. Such number coding is useful for augmenting a coding system, such as a color code, and thereby effectively multiplying the number of "colors" (distinguishable sub-types). It can be applied advantageously, for example, in multiplexed nucleic acid or protein analysis. In one embodiment, members of a pair of probes are encoded by N-coding of solid phase carriers of the same color, but each of several such different pairs of probes will be associated with a carrier type of a different color. This embodiment is useful, for example, in multiplexed mutation analysis, where a color code can be augmented (effectively doubled) by N-coding carriers displaying pairs of probes, where the pair members are complementary to, respectively, a wild-type and variant allele. In another embodiment, sets of probes complementary, for example, to a polymorphic region and to each of the four possible bases at a designated polymorphic position within the region, are encoded by N-coding of solid phase carriers of the same color, and each of several such different sets of probes will be associated with a carrier type of a different color. In yet another embodiment, where, for example, there are multiple epitopes associated with a particular antigen, or where one merely wishes to increase the available coding, proteins (peptides) representing epitopes can be associated with a solid phase carrier and used to screen biological samples for reactive proteins or antibodies. This may be used, for example, where pairs or small sets of epitopes are associated with a particular antigen, hi such case, the C-coding can be augmented by N-coding of solid phase carriers of the same color, where such a carrier subset carries the pairs or set of proteins conesponding to such pairs or sets of epitopes, as applicable.
The solid phase carriers preferably are microparticles which are assembled into planar arrays of particles on a substrate for use in the Random Encoded Array Detection
(READ™) format of analysis, as disclosed in Serial No. 10/032,657, filed 12/28/2001, entitled "Multianalyte Molecular Analysis Using Application-Specific Random Particle Arrays" (incorporated by reference). The methods herein are particularly useful in applications requiring, for each analyte, the determination of one among only a finite number of possible assay scores. Specifically, N-coding of pairs of solid phase carriers is practical because only a small number of carrier subtypes, and in the case of mutation analysis only two carrier subtypes, need be distinguished, and a unique code is trivially available. Brief Description of the Drawings Figs. 1A to1 ID show assay results of numerical coding for detecting the F508 mutation using elongation detection, in the form of a series of four histograms, where, in each histogram, the number of beads displaying a signal of a certain intensity is plotted against intensity. Fig. 2 depicts the native conformation of a protein which can be bound to either of two antibodies; the generation of synthetic peptide fragments corresponding to different linear epitopes of the protein and attaching the fragments to beads; and, the binding of labeled antibodies to the peptide fragments on the beads. A labeled secondary antibody could be used for detection, if the peptide fragments were initially bound by an unlabeled antibody (not shown). Fig. 3 depicts a coding system with four different C-codes ("colors") to encode bead types, for use in detecting antibodies against eight different peptides (PI to P8). Fig. 4 depicts a histogram showing the number of beads displaying a certain intensity as a function of intensity, for detection of the "V" and "W" alleles using different numbers of carriers displaying probes which bind to the V or the W alleles. In the preferred case, the histogram has two distinct, non-overlapping peaks. Fig. 5 depicts a plot of results as show in Fig. 4, but for overlapping histogram peaks in this case. Fig. 6 is a histogram representing the probability of selecting a given number of carriers ("beads") of particular types of 70 subtypes, based on the evaluation of 40
random encoded arrays of beads, where the anticipated number of beads of each type was about 60. A total of about 3,500 beads (of 70 types) are anticipated to be present in each of the 40 bead arrays, based on an average 90% occupation of available sites. For each type, the CV was calculated over the population of 40 arrays evaluated. Fig. 7 is a histogram plot as in Fig. 6, but for another type of beads. Fig. 8 is a plot of confidence interval against number of beads, at different CVs and significance levels (ά). Fig. 9 is Table 1, showing results from three synthetic peptides P6, P8, and P12 affixed to the same colored microspheres in separate reactions. Fig. 10 is Table 2, showing bead types with different peptide pairs associated with beads. Fig. 11-13 are, respectively, Table 3A to 3C, showing beads reactive with different samples. DETAILED DESCRIPTION N-Coding of Pairs ("Doublets"): Mutation Analysis and Carrier Screening - In the multiplexed analysis of mutations, a pair of probes is provided for each mutation of interest, a first probe designed to identify the "Wild-Type" ("W") and a second probe designed to identify the "Variant" ("V"). Identification may invoke hybridization (as disclosed in US Application Serial No. 10/847,046, filed 5/17/2004 "Hybridization- Mediated Analysis of Polymorphisms (hMAP)," both being incorporated herein by reference) or elongation (as disclosed in US Application Serial No. 10/271,602, filed 10/15/2002 entitled "Multiplexed Analysis of Polymorphic Loci by Concurrent Interrogation and Enzyme-Mediated Detection," incorporated herein by reference). For every type of C-coded carrier, a number w := ncW, of carriers displaying the W-probe, and a number v := nc v (where ncV ≠nc ) of carriers displaying the V-probe are provided. ncW and ncV are selected so as to differ by a quantity Δnc, which is sufficiently large to ensure that an unambiguous call can be made in view of the practical considerations and requirements discussed above. The selection criterion for ncW and ncV is discussed in greater detail below.
Each pair of probes can encounter only three possible scenarios: the W allele, the V allele or a heterozygous (H) target. The actual outcome is determined by "counting, comparing and (optionally) confirming" as follows: Count the number of carriers, p := nc+, (of, e.g., type C) which score positive, as determined from the intensity of signal recorded after completion of an assay designed to detect the presence of the Wand/or Vform of the subsequence of interest; Count the number of carriers, n := nc-, (of type C) which score negative; Compare: IF: p/w ~ 1: THEN: W-allele; Confirm : n /v ~ 1; IF NOT, THEN IF p/v~ l: THEN: V-allele; Confirm: n/w ~ 1; IF NOT, THEN IF p/(w+v) ~ 1: THEN: H; Confirm: n/(w+v) ~ 0; N-Coding of Multiplets: Polymorphisms and Antibody/Epitope Pairs The N-coding system also could be used to detect single-nucleotide polymorphisms (SNPs). hi such case, for example using eMAP™ detection, one would generate four different sets of probes, each complementary to the subsequence of interest but distinguished in that each different set would carry, at the 3' terminal probe position juxtaposed to the SNP site, one of four different nucleotides: A, C, G or T. Each set of probes would be attached to a carrier to form a carrier subtype, and there would be different numbers of each such subtype. The possible outcomes in such case would multiply to one positive for each of a possible four, or any combination of two positives for heterozygotes. N-coding also could be used in assays for detecting the presence, in a sample, of antibodies capable of binding to peptides displayed on beads, or, in the reverse situation, for detecting peptides in a sample where the antibodies are displayed on beads. In such case, N-coding could be used for increasing the number of available codes, where, for
example, color coding is used to discriminate among peptide-antibody combinations. That is, certain combinations can be encoded using carriers of the same color, by N- coding of such same-colored carriers to discriminate among such different combinations. An assay for detecting antibodies can be of particular utility for detecting auto-antibodies in a patient, in support of a diagnosis of autoimmune disease. N-coding is useful when beads of a single color 'are employed, but are functionalized to display three different peptides to detect antibodies in a sample directed against one or more of the peptides, each peptide representing one specific epitope of the cognate antigen. Different numbers of beads displaying each of the three peptides would be pooled; i.e., X beads display peptide PI, Y beads display peptide P2, and Z display peptide P3. The pooled beads are then placed in contact with a sample which may contain antibodies against one or more of the peptides PI, P2 or P3. The sample is removed, and the beads are exposed to a labeled, secondary detection antibody which binds to any antibodies bound to the peptides on the beads (e.g., a goat anti-human antibody, if the sample is human); the assay signals are then recorded. The assay would have been first calibrated so that differences in relative signal can be correlated with numbers of labeled beads; i.e., one would be able to determine, based on the relative signal, whether X, Y, Z or a combination or sub-combination of X, Y and Z beads generated a signal, indicating they had bound to antibodies in the sample. For example, the N-coding design in Table 2A may be used. Decoding the signal, therefore, indicates which specificepitope (or epitopes, if the signal indicates that a combination or subcombination of X, Y and Z beads generated a signal) were recognized by antibodies in the sample. This will permit classification of autoantibodies into subtypes for each autoantigen. This assay system would be adequate where one was detecting relatively small numbers of different antibodies, and using numbers of beads where X, Y and Z are widely different. As noted above, N, the total number of beads, must have a unique decomposition, and the larger the numbers of peptides PI ...Px, the more difficult it is to construct such a unique decomposition. This assay system could also be used where a population of beads has uniquely encoded (e.g., C-coded) populations, N-coding can be enhanced to distinguish among a
number of particles exceeding the number of available C-codes. For example, as shown in Fig. 3, four C-coded bead populations are each associated with, respectively, proteins or peptides PI, P2, P3 and P4, and members of each bead type also are associated with proteins or peptides P5, P6, P7 and P8. It may be advantageous to have multiple peptides attached to beads in this manner, if one is mapping non-linear epitopes, as combinations of epitopes may, when attached to the beads, assume a configuration in which they react with antibodies, in the same manner as they do in vivo. As illustrated by the decompositions of binding shown in Tables 2 to and 3A to 3C (Figs. 10-13), this encoding design can allow one to distinguish among antibodies directed to eight proteins or peptides, PI to P8, or certain combinations thereof.
Number Coding under Uncertaint- Were carriers of each subtype identical, and experimental conditions perfect, then signals from each carrier of a given subtype would be identical, histograms of signal intensities recorded from instances of each subtype would contain δ-function peaks, and subtypes would be discriminated merely by ensuring, for the pair, w := ncW ≠v := ncV, or, for multiplets, a unique numerical decomposition, hi practice, however, signals from nominally identical carriers display a finite variance, resulting, for example, from the chemical heterogeneity of carriers, statistical fluctuations in analyte capture to carrier-displayed probes and noise in signal acquisition. Under such conditions, exceptionally high signals recorded from nominally "negative" carriers may exceed exceptionally low signals recorded from nominally "positive" carriers, producing overlap of peaks for the W and V alleles in a histogram of intensities recorded from all carriers of a particular code, e.g., type C. Confidence Intervals - A finite variance in assay signals recorded from carriers of different type will of course affect the reliability of discrimination between W and V alleles regardless of the method of coding. Thus, the standard methods of statistical analysis apply to the construction of confidence intervals - once the step of partitioning of the carrier population into types has been accomplished. For example, if carriers for W and V probes were color coded, the construction of confidence intervals would proceed by the usual standard methods of statistical analysis, applied to intensities, Ly I, Iw 2 , • • •, Iw w recorded from the w carriers displaying the W- probe and to intensities, Iγ ι, Iv 2 , ■ ■ ■ v v recorded from the v carriers displaying the V-
probe. These sets of intensities yield mean values, Overline {I } and Overline {Iγ}, with the respective variances, Sw 2 and Sv 2. Under the assumption that the w and v intensities in the two sets represent independent observations, the t-distribution provides an expression relating the values (w, Overline {Iw}, Sw 2) and (v, Overline {Iv}, Sv 2) to the desired probabilities that confidence intervals constructed from the two sets of observations and placed on the mean values of the observed intensities contain the true mean values < Iw > and < Iy >. Alternatively, the t-distribution can be applied in this circumstance to test whether the means of the two intensity populations are the same (or not) (see e.g, Chapt. 9 in "Principles of Statistics", M. G. Buhner, Dover Publications, 1979, incorporated by reference). The construction of a desired confidence interval to be placed on mean values requires a minimal number of observations, or here, a minimal number of carriers of each type, thereby setting a lower bound on w and v. Stated otherwise, decreasing the number of beads for a given CV and mean value increases the confidence interval. Figure 8 shows the confidence interval for cases where the assay CV is 10% and
30%. The interval defining the range of the calculated mean is plotted against the minimum number of beads NB necessary for significance levels of 90%, 95% and 99%. A larger number of beads ensures that the confidence interval is smaller. Partitioning — In contrast to other encoding methods such as C-coding, N-coding is subject to additional uncertainty as a result of peak overlap and equivalent ambiguities affecting recorded assay signal intensities. Thus, referring to N-coding of pairs in the context of mutation analysis, partitioning into + and — subtypes may not be obvious by mere inspection of the data, as presumed in the Count-Compare-Confirm procedure of determining subtypes. In such a circumstance, the partitioning step may be performed by introducing a suitable optimality criterion, assuming, for the moment, that w := ncW and v := ncV are known, for example, by explicit counting of carriers of each subtype prior to pooling. While described here for a pair of subtypes, the partitioning process is readily generalized to the discrimination of other than pairs by considering two or more thresholds in the partitioning step in accordance with the known instances for each possible subtype.
Construct a histogram of intensities recorded from all carriers sharing one C- code;
IF (histogram has only a single peak such that : n+/(w + v) ~ l) THEN: H ELSE find an optimal threshold, T, such that:
(n+(T) - w)A2 = min AND (n- (T) - v) 2 = min THEN: W allele OR (n+(T) - v)A2 = min AND (n- (1) - w) 2 = min THEN: V allele
wherein n+(T) andn-(τ) are obtained by integration over the two partitions produced by partitioning of the histogram in accordance with the selection of the threshold T. In the event of peak overlap, the experimentally recorded numbers p := n+(τ) of "positive" intensities, L:+ , I2 + , ..., Ip + and n := n-(τ) of "negative" If , I2 " , ..., In ~, will depend on the threshold T. For example, exceptionally low signals recorded from nominally "positive" carriers may exceed exceptionally high signals recorded from nominally "negative" carriers, and once a threshold is selected, a certain number of "false negatives" and "false positives" will result. That is, carriers whose assay signal intensities fall into the peak overlap region may be assigned incorrect codes. The numbers p and n will then differ from the numbers w of particles displaying a probe matching the W-allele and v of particles displaying a probe matching the V-allele. Accordingly, to ensure robust N-coding, the choice of w and v must be such that peak overlap will not corrupt the code (Fig. 5). A first condition ensuring robust N-coding may be based upon the observation that the maximal number, e, of errors in carrier type assignments will result when all errors either are false negatives, n -> n+e, p ->p-e, or false positives, n -> n-e, p - p+e, and that this maximal number will be an increasing function of the magnitude of peak overlap, Σ: e = e(∑). That is, extreme values of the threshold, T, either to the right extreme of the overlap region or to the left extreme of the overlap region will produce the greatest deviations in n and p (Fig. 5).
Thus, a conservative criterion guiding the selection of w and v can be stated as follows:
IF (without overlap: p > n) THEN ensure p-e > n+e with overlap. ELSE IF (without overlap: p < n) THEN ensure p+e < n-e with overlap To ensure that these conditions are met, N-coding is preferably used only when it can be ensured that the N-coded subtypes produce substantially different assay signal intensities, thereby minimizing peak overlap . That is, N-coding in accordance with the present invention preferably is used to represent discrete outcomes of an assay such that overlap between partitions in an intensity histogram is negligible. This is ensured by employing N-coding to represent assay outcomes only when the observed mean assay signal intensities are separated by at least one standard deviation, and preferably three standard deviations, to minimize the maximal number of possible false negatives or false positives. Alternatively, if a peak overlap of magnitude Σ is anticipated, w and v must be chosen in accordance with a design criterion such as the one stated above. Number Fluctuations - h addition to accounting for experimental uncertainty in the determination of the values of p and n, allowance also must be made for statistical uncertainty regarding the values w and v themselves. Such uncertainty can arise as a result of fluctuations in the number of particles contained in aliquots (of nominally identical volume) that are prepared in the course of practicing the invention. For example, if, as in READ™, carriers are placed into a random array in a designated area of a planar substrate, fluctuations in the number of each carrier subtype included in the array are expected to be in accordance with a certain probability distribution whose mean is related to the concentration of the carrier reservoirs, preferably maintained in the form of a stable suspension, as described in Example 3. Accordingly, actually realized values of w and v are determined only to within a certain range of possible values, namely w* = w ± δw and v* = v ± δv, as shown by comparison of Figs. 6 and 7, and allowance must be made for this uncertainty in the selection of the design values for w and v. For example, in the case of Poisson statistics,
δw <w>, δv ~ <v>, i.e., significant deviations of w and v are possible. Thus, a necessary condition to be satisfied by a robust N-code may be stated as follows:
IF (N-code is to ensure v* < w*) : THEN select v, w such that v + δv < w - δw ELSE IF (N-code is to ensure v* > w*) : THEN select v, w such that v - δv > w + δw In addition to this condition, a robust N-code also must take into account experimental uncertainties such as those discussed above which may affect the observed counts, p and n. Thus, a more general criterion guiding the selection of w and v can be stated as follows:
IF (N-code is to ensure ( ]p-w*\ < \p-v*\ ) AND ( \n-v*\ < \n-w*\ ) /* W allele */ THEN ensure max{ \p±e - w*\} < min{ \p±e - v*\ ^AND max{ \n±e - v*\ } < minf \ n±e - w*\ } ELSE IF (N-code is to ensure ( p-v*\ < p-w*\ ) AND ( \n-w*\ < \n-v*\ ) /* V allele */ THEN ensure max{ \p±e - v*\} < minf \p±e - w*\} AND max{ \n±e - w*\ } < minf \ n±e - v*\ } These multiple conditions to be placed upon a proper choice of w and v for robust N-coding restrict the practical use of N-coding as a general encoding methodology, as discussed at the outset. N-coding is then particularly useful in connection with a color code ("C-code") because it reduces the set of color codes required for encoding of a given number of probes. For example, for the ACMG panel of 25 CF mutations requiring, instead of 50 color codes, only 25 color codes are required. Conversely, N- coding extends by a factor of two the coding complexity of a given set of color codes, thereby facilitating the process of manufacturing sets of color-encoded particles. Therefore, provided that N codes are constructed in accordance with the design rules outlined above, N coding can be used as part of a coding system involving color or other encoding markers, for certain of the carriers in a larger group, where such carriers are encoded identically but for their number codes.
EXAMPLES
EXAMPLE 1: N-Coding of eMAP Probes for Detection of ΔF 508 CF Mutation Mutation analysis was performed by placing members of a probe pair, designed to detect wild type and the ΔF 508 cystic fibrosis ("CF") mutation on beads of the same color, but selecting different numbers of V-beads and W-beads. Ass ay results were analyzed by recording signal intensities indicating hybridization of probe and target, and by analyzing these results in accordance with the histogram representation and CCC procedure described herein. Protocols- Wild type (W) and mutant (V) probes relating to the ΔF 508 CF mutation fixed to beads of the same color, and beads were pooled at different ratios of W to V probes and assembled into planar arrays in accordance with the READ™ format. On a first chip, the ratio of W:V was 1:5, and on a second chip the ratio of W:V was 5:1. For detection of hybridization of probe and target, an elongation assay ("eMAP" see US Application Serial No. 10/271,602, filed 10/15/2002, incorporated by reference) was used. Known wild type and ΔF 508 heterozygous samples were applied to both types of chips, and histograms were generated. See Figs. 1A to ID. BEAD FUNCTIONALIZATION: Aliquots of a suspension of a bead designated G3H (a blue-green tosylated bead modified with Bovine Serum Albumin ("BSA") in accordance with the methods disclosed in a co-pending application was functionalized with each of the following amino-modified DNA probes: 508W: Sequence: GGC ACC ATT AAA GAA AAT ATC ATC (SEQ ID NO. 1) ΔF 508: Sequence: GGC ACC ATT AAA GAA AAT ATC ATT (SEQ ID NO. 2) The following protocol was used to attach these probes to the BSA-modified beads. BSA Protocol: 1. Add lOOμL of beads to a tube containing 500μL PBST, mix with vortex 2. Centrifuge for 1 min and remove the supernatant 3. Add 500μL MES (0. IM, pH 4.5), mix with vortex, 4. Centrifuge for 1 min and remove supernatant 5. Prepare 0.05M of EDAC in MES right before use: a. Take EDAC out of freezer and let it warm to room temperature for 30 min
b. Add 4mL of MES (0. IM, pH 4.5) to 40mg EDAC, mix with vortex 6. Add 500μL of EDAC solution to each tube of beads 7. Add lOμL probe (lOOμM) to each bead suspension 8. Allow the beads to react for 1 hour at room temperature with end-over-end mixing 9. Add lOOμL of PBST to each tube after reaction, mix with vortex, centrifuge for 1 min, and remove supernatant 10. Wash beads twice with 500μL of PBST and resuspend the beads in lOOμL of TBS-2. BEAD POOLING: Two pools were prepared using beads functionalized with 508W and ΔF 508 probes, as well as beads modified with OligoC (negative control) and probes matching beta-actin (positive control). In Pool A, the ratio of 508WT to F508 was 1:5, while in Pool B, the ratio was 5:1. The following pooling protocol was used: 1. Add each of the four modified beads to an empty tube according to the volumes noted below 2. Wash beads once in lOOμL lOmM Tris 3. Resuspend beads in 36 μL 1 OmM Tris
Pool A :
ASSEMBLYOFRANDOMENCODEDBEADARRAYS: A total of four arrays were assembled on the upper surface of a substrate (a "chip"), where two of these arrays were composed of Pool A, and the other two were composed of Pool B. ELONGATION ASSAY: For the elongation, 6.5 μL PCR product was extracted from known WT or M samples and placed into a PCR tube, to which 2μL Exo-sap was added. The mixture was incubated at 37°C for 25 min and 80°C for 15 min (in a thermocycler). Thereafter, λ exonuclease was used for digestion into single stranded DNA. The reaction mixture included each of: dGTP, dTTP , dATP and dCTP. Following PCR amplification, the following Ex- 10 primers were used in multiplexed PCR: SEQ ID NO. 3: GGC GTC CCA AAA GGG TCA GTG AGC CTT CAG AGG , GTA AAA T SEQ ID NO. 4: GCG GTC CCA AAA GGG TCA GTC AGT AGC TTA CCC ATA GAG G The results of the assay are shown in Figs. 1 A to ID, in the form of a series of four histograms. In each histogram, the number of beads displaying a signal of a certain intensity is plotted against intensity. In Fig. 1 A, a wild-type ("W") sample is added to a bead pool in which the ratio of the number of beads functionalized with probes complementary to the W subsequence to that of beads functionalized with probes complementary to the variant ("V") is 1 to 5. The histogram has two peaks, but, as expected, the peak corresponding to the beads producing a positive signal has only a small area, indicating that only a small number of beads produce a positive signal. In Fig. IB, the sample is the same, but the ratio of beads of each type is reversed, and, as expected, the reverse ratio of peak areas is observed in the histogram. In Fig. IC and ID, the sample is heterozygous for W and V, and, as expected, irrespective of the ratio of V and W, a large number of beads produce a positive signal. Example 2 - Detecting Auto-antibodies As shown in Table 1 (Fig. 9), three synthetic peptides P6, P8, and P12 are affixed to the same colored microspheres in separate reactions. These synthetic peptides are biotinylated at their N-termini with an 18-carbon spacer and immobilized by way of
biotin-neutravidin complex formation. Beads are pooled, for example, at ratios of one part of P6-functionalized beads, two parts of P8- functionalized beads, and four parts of PI 2- functionalized beads and an array is assembled on the surface of a silicon chip (Beadchip™). Beadchips were incubated in separate experiments with two 1:20 diluted serum samples positive for antibody directed against a lupus characteristic antigen, SCL-70 (#1764 from BiosPacific and #68933 from METIC Lab. After removing non-reacted antibodies, specific antibodies captured by the peptides were visualized using a fluorescently labeled goat-anti-human IgG antibody-conjugate. Decoding and assay images were acquired using a microscope equipped with a CCD camera, as in the previous example. The assay signals were extracted, and the Pi/P7 ratios (peptide-specific signal intensity vs. the signal intensity of negative control peptide, P7) were calculated. Beads with an intensity value significantly higher than that of the negative control were designated positive. The presence of P6, P8 or P12-specific antibodies was determined by the relative numbers of positive beads. As shown in Table 1 (Fig. 9), assaying sample #1764 yielded 300 positive beads, meaning the positive beads captured anti-P8 (100 positive beads) and anti-P12 (200 positive beads) antibodies. Sample #68933 yielded 150 positive beads, meaning the positive beads captured anti-P6 (50 positive beads) and anti-P8 (100 positive beads) antibodies.
Example 3 - Number Fluctuations in Random Encoded Bead Arrays To prepare a pool of 50 types of encoded carriers in the form of polymer microparticles ("beads") of 3μm diameter, 50μl aliquots of each bead type are taken from a reservoir containing 1ml of a stable suspension and split in order affix to each particle of a specific type a selected chemical entity such as an oligonucleotide probe. Next, 5μl aliquots of probe-functionalized beads are taken from each reaction container and pooled to produce 250μl of suspension containing 50 types of functionalized beads. Finally, in accordance with the Random Encoded Array Detection (READ) format, a 0.5μl aliquot of pooled bead suspension is placed onto a planar silicon substrate, covering an area of approximately 1mm which includes a designated area of 300μm by 300μm, thus approximately 10% of the total area, for assembly of a planar array of 4000.
Under these assumptions about the relative size of aliquot ("sample") and reservoir, and about the relative size of designated area and total area of substrate, bead types will be distributed about the mean value, say the average density of particles in the original volume of suspension, in accordance with a Poisson distribution such as those shown in Figs. 6 and 7. The terms, expressions and examples hereinabove are exemplary only, and not limiting, and the invention is defined only in the claims which follow and includes all equivalents of the subject matter of the claims. Unless otherwise indicated, steps in method claims can be performed in any order, including but not limited to the order set forth in the claims.
Claims
1. A method of distinguishing members of pairs of solid phase carriers, where members of a particular pair display a probe sequence complementary capable of hybridizing with one of two different subsequences, said subsequences having substantial homology and said subsequences, individually or together, may be present in a target nucleic acid sample derived from a eukaryote, and where the number of members displaying each said probe sequence is known, comprising: reacting the target nucleic acid sample with the members of the pairs of solid phase carriers; determining the number of members generating a positive signal; comparing said number of members generating a positive signal with the number of members displaying different probe sequences; and determining whether the target nucleic acid sample is homozygous for either of the subsequences, or is heterozygous.
2. The method of claim 1 wherein following reaction with the target sample, members having a negative signal are counted,' and the number is used to confirm whether the target sample is homozygous for either of the subsequences or is heterozygous.
3. The method of claim 1 wherein the correlation obeys the formula: where the total number of carriers, nc, = total number of carriers carrying the probe capable of hybridizing with one of the subsequences, designated ncV, + total number of carriers carrying the probe capable of hybridizing with the other of the subsequences, designated ncW; and the number of carriers which are positive following reaction is designated nc+, then: when nc+/ncW ~1; the sample is homozygous for the one subsequence; when nc+/ ncV «1 ; the sample is homozygous for the other subsequence; and when nc+/(ncV + ncW) «1; the sample is heterozygous.
4. The method of claim 3 where the number of carriers which are negative following reaction is designated nc-, the results of the method are confirmed or refuted as follows: where the method of claim 3 indicates the sample is homozygous for N: nc-/ ncV~ 1; where the method of claim 3 indicates the sample is homozygous for V: nc-/ ncW ~ 1 ; or where the method of claim 3 indicates the sample is heterozygous: nc-/ (ncW+ncV) ~ 0.
5. The method of claim 1 wherein the carriers are beads.
6. The method of claim 1 wherein the positive carriers are determined by an assay detecting hybridization of labeled target to probes, or by an assay in which hybridization of the probe and target sample is followed by elongation to label the probe.
7. The method of claim 6 in which positive carriers are determined by detecting an optical signal.
8. The method of claim 1 wherein each carrier pair is encoded to distinguish it from other carrier pairs.
9. The method of claim 8 wherein the encoding is by color.
10. A method of expanding the set of distinguishable codes for encoding particles in a bioassay of a sample, where analytes are distinguished using encoded particles displaying different ligands, where ligands which bind to different analytes can be distinguished through the codes, comprising: forming groups, each group made up of different numbers of particles having the same code, where members of each group display up to four different ligands, and wherein the number of particles in each group displaying the same ligand has a unique decomposition into one or more summands, such that no partial sum of one or more summands can be obtained in any other way of combining summands, and no summand is itself the sum of two or more of the other summands; reacting the sample with the particles; determining for each group of particles, the number of particles generating a positive assay signal; comparing for each group of particles, said number with the number of particles displaying each said different ligand; and determining for each group of particles, which analytes which bind to the ligands attached to the particles in a group, are present in the sample.
11. The method of claim 10 used to analyze the polymorphic form of a nucleic acid analyte present in a genomic sample, wherein each group of encoded particles is functionalized with one of four oligonucleotide probes, each probe differing by having one of the nucleotides A, C, G or T in the 3 ' terminal position.
12. The method of claim 11 wherein a positive assay signal is generated by an elongation reaction.
13. A method of expanding the distinguishable set of codes for coding particles displaying different ligands, each ligand being a peptide or an antibody, where the particles are used in a bioassay of a sample, and where ligands which bind to different analytes can be distinguished through the codes, comprising: forming groups of different numbers of particles having the same code, where members of each group display up to four different ligands, and wherein the number of particles in each group displaying the same ligand has a unique decomposition into one or more summands, such that no partial sum of one or more summands can be obtained in any other way of combining summands, and no summand is itself the sum of two or more of the other summands; reacting the sample with the particles; determining for each group of particles, the number of particles generating a positive assay signal; comparing for each group of particles, said number with the number of particles displaying each said different ligand; and determining for each group of particles, which analytes which bind to the ligands attached to the particles in a group, are present in the sample.
14. The method of claim 13 wherein the ligands are peptides used to detect specific epitopes of auto-antibodies in a sample.
15. The method of claim 14 wherein determining the binding between peptides and antibodies is by a secondary detection antibody which binds to the auto-antibodies bound to the peptides.
16. The method of claim 14 wherein the solid phase carriers are beads encoded by different colors, and different colors correspond to different groups of peptide ligands, each such group of peptides corresponding to epitopes of a specific autoantibody.
17. The method of claim 14 wherein two or more different types of peptides are attached to beads of the same color.
18. In a method of distinguishing members of pairs of solid phase carriers, where each pair is encoded differently from other pairs and the number of each member of a pair is used as an additional code to distinguish it from the other member of the same pair, where each member of a pair displays a probe sequence capable of hybridizing with one i of two different alleles, said alleles having substantial homology and said alleles, individually or together, may be present in a target nucleic acid sample derived from a eukaryote, and wherein the binding of a probe to either allele generates an assay signal correlating with the number of members displaying probes binding in such manner, and where: w is the designated number of carriers carrying the probe for the one of the alleles and δw represents the limit of the range of possible values to which w can be detected, then w* = w ± δw; v is the number of carriers carrying the probe for the other allele and δv represents the limit of the range of possible values to which v can be detected, then v* = v + δv; for detecting the one allele, p represents the number of carriers displaying a positive signal and n represents the number of carriers displaying a negative, such that p ~ w*, n ~ v*; for detecting the other allele, p represents the number of carriers displaying a positive signal and n represents the number of carriers displaying a negative signal, such that p ~ v*, n ~ w*; and e represents the number of carriers which produce erroneous results, either false positive or false negative; a method of optimizing the design of the number coding for each pair, comprising: (i) designing a code for detecting the one allele such that |p-w*| < |ρ-v*| and |n-v*| < |n- w*| by setting the maximum possible value of (p±e - w*) to be less than the minimum possible value of (p+e - v*) and the maximum possible value of (n±e - v*) to be less than the minimum possible value of (n±e - w*); or
(ii) designing a code for detecting the other allele such that |p-v*| < |p-w*| and |n-w*| < |n-v*| by setting the maximum possible value of (p+e - v*) to be less than the minimum possible value of (p±e - w*) and the maximum possible value of (n±e - w*) to be less than the minimum possible value of (n± e - v*).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50429403P | 2003-09-18 | 2003-09-18 | |
US60/504,294 | 2003-09-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005029705A2 true WO2005029705A2 (en) | 2005-03-31 |
WO2005029705A3 WO2005029705A3 (en) | 2005-09-01 |
Family
ID=34375473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/030499 WO2005029705A2 (en) | 2003-09-18 | 2004-09-17 | Number coding for identification of subtypes of coded types of solid phase carriers |
Country Status (2)
Country | Link |
---|---|
US (2) | US7927796B2 (en) |
WO (1) | WO2005029705A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6411210B2 (en) * | 2014-12-26 | 2018-10-24 | 富士通コンポーネント株式会社 | Touch panel unit |
US11140298B2 (en) * | 2019-12-19 | 2021-10-05 | City University Of Hong Kong | Universal color coding system, and a system and a method of manipulating colors using such color coding system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567627A (en) * | 1991-07-16 | 1996-10-22 | Trans-Med Biotech, Incorporated | Method and composition for the simultaneous and discrete analysis of multiple analytes |
Family Cites Families (496)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4575407A (en) * | 1962-12-03 | 1986-03-11 | Diller Isaac M | Product and process for the activation of an electrolytic cell |
US3329638A (en) | 1963-09-05 | 1967-07-04 | Monsanto Co | Multilayered polymeric latices with hydrophilic surface layer |
US3574614A (en) | 1967-01-06 | 1971-04-13 | Xerox Corp | Process of preparing multiple copies from a xeroprinting master |
US3989775A (en) | 1971-03-01 | 1976-11-02 | Bakelite Xylonite Limited | Method of making a retro-reflective beaded material |
US3790492A (en) * | 1971-03-11 | 1974-02-05 | Atomic Energy Commission | Method for production of uniform microspheres |
US3982182A (en) | 1973-08-13 | 1976-09-21 | Coulter Electronics, Inc. | Conductivity cell for particle study device |
US3998525A (en) | 1973-10-26 | 1976-12-21 | American Cyanamid Company | Edge lighted electrochromic displays |
US3957741A (en) | 1974-01-17 | 1976-05-18 | California Institute Of Technology | Crosslinked, porous, polyacrylate beads |
BE833512A (en) | 1974-09-17 | 1976-03-17 | NEW COMPOSITION OF LATEX LOADED WITH A HYDROPHOBIC COMPOUND, ITS PREPARATION AND ITS PHOTOGRAPHIC APPLICATION | |
DE2502621C3 (en) | 1975-01-23 | 1978-09-14 | Kernforschungsanlage Juelich Gmbh, 5170 Juelich | Measurement of elastic and dielectric properties of the membrane of living cells |
GB1568111A (en) * | 1975-07-22 | 1980-05-29 | Phosphor Prod Co Ltd | Electroluminescent devices |
US4275053A (en) | 1975-08-14 | 1981-06-23 | Mt. Sinai School Of Medicine Of The City University Of New York | Blood cell typing and compatibility test procedure |
US4003713A (en) * | 1975-08-14 | 1977-01-18 | Bowser Everett N | Multiple test tube evaporator |
US4046667A (en) | 1975-10-30 | 1977-09-06 | Pen Kem, Inc. | Microelectrophoresis apparatus |
US4143203A (en) * | 1976-03-19 | 1979-03-06 | Amicon Corporation | Particulate support material |
US4326008A (en) | 1976-08-27 | 1982-04-20 | California Institute Of Technology | Protein specific fluorescent microspheres for labelling a protein |
US4075013A (en) * | 1976-09-13 | 1978-02-21 | Ward Anthony T | Electrophotochemical preparation of selenium photoconductive members |
US4102990A (en) | 1977-12-05 | 1978-07-25 | General Electric Company | Electrophoretic assay for antigen-antibody reaction based on particle-particle coupling |
AU530410B2 (en) | 1978-02-21 | 1983-07-14 | Sintef | Preparing aqueous emulsions |
US4258001A (en) * | 1978-12-27 | 1981-03-24 | Eastman Kodak Company | Element, structure and method for the analysis or transport of liquids |
US4267235A (en) | 1979-03-19 | 1981-05-12 | California Institute Of Technology | Polyglutaraldehyde microspheres |
IT1145696B (en) | 1979-08-24 | 1986-11-05 | Rhone Poulenc Ind | PREPARATION PROCEDURE FOR MAGNETIC PEARLS OF VINYLAROMATIC POLYMERS |
US4421896A (en) | 1979-11-13 | 1983-12-20 | The Dow Chemical Company | Method of coupling a protein to a polymer particle containing hydrazide groups in a polymer latex and the products formed therefrom |
US4806776A (en) * | 1980-03-10 | 1989-02-21 | Kley Victor B | Electrical illumination and detecting apparatus |
FR2480764B1 (en) | 1980-04-18 | 1985-10-04 | Rhone Poulenc Spec Chim | LATEX OF MAGNETIC POLYMERS AND PREPARATION METHOD |
US4383529A (en) | 1980-11-03 | 1983-05-17 | Wescor, Inc. | Iontophoretic electrode device, method and gel insert |
DE3116995A1 (en) | 1981-04-29 | 1982-11-25 | Röhm GmbH, 6100 Darmstadt | LATEX FOR IMMOBILIZING BIOLOGICALLY EFFECTIVE SUBSTANCES |
JPS5844340A (en) | 1981-09-10 | 1983-03-15 | Kureha Chem Ind Co Ltd | Method and apparatus for measuring electrophoretic mobility |
NO155316C (en) | 1982-04-23 | 1987-03-11 | Sintef | PROCEDURE FOR MAKING MAGNETIC POLYMER PARTICLES. |
US4717655A (en) | 1982-08-30 | 1988-01-05 | Becton, Dickinson And Company | Method and apparatus for distinguishing multiple subpopulations of cells |
US4499052A (en) * | 1982-08-30 | 1985-02-12 | Becton, Dickinson And Company | Apparatus for distinguishing multiple subpopulations of cells |
US4994373A (en) * | 1983-01-27 | 1991-02-19 | Enzo Biochem, Inc. | Method and structures employing chemically-labelled polynucleotide probes |
US4487855A (en) | 1983-02-15 | 1984-12-11 | Shih Yen Jer | Colored latexes; methods for making same and colored finely divided products |
US4824941A (en) | 1983-03-10 | 1989-04-25 | Julian Gordon | Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems |
US4672040A (en) | 1983-05-12 | 1987-06-09 | Advanced Magnetics, Inc. | Magnetic particles for use in separations |
DE3322373C2 (en) | 1983-05-19 | 1986-12-04 | Ioannis Dr. 3000 Hannover Tripatzis | Test means and methods for the detection of antigens and / or antibodies |
US4497208A (en) * | 1983-06-23 | 1985-02-05 | Matec, Inc. | Measurement of electro-kinetic properties of a solution |
US4591550A (en) | 1984-03-01 | 1986-05-27 | Molecular Devices Corporation | Device having photoresponsive electrode for determining analytes including ligands and antibodies |
US4665020A (en) | 1984-05-30 | 1987-05-12 | United States Department Of Energy | Flow cytometer measurement of binding assays |
US4647544A (en) * | 1984-06-25 | 1987-03-03 | Nicoli David F | Immunoassay using optical interference detection |
US4774189A (en) | 1984-12-24 | 1988-09-27 | Flow Cytometry Standards Corp. | Fluorescent calibration microbeads simulating stained cells |
US5073498A (en) | 1984-12-24 | 1991-12-17 | Caribbean Microparticles Corporation | Fluorescent alignment microbeads with broad excitation and emission spectra and its use |
US4702598A (en) | 1985-02-25 | 1987-10-27 | Research Corporation | Flow cytometer |
US4613559A (en) | 1985-04-01 | 1986-09-23 | Xerox Corporation | Process for colored toner compositions with controlled charges thereon |
US5354825A (en) | 1985-04-08 | 1994-10-11 | Klainer Stanley M | Surface-bound fluorescent polymers and related methods of synthesis and use |
US4806313A (en) * | 1985-04-12 | 1989-02-21 | E. I. Du Pont De Nemours And Company | Rapid assay processor |
US4753775A (en) | 1985-04-12 | 1988-06-28 | E. I. Du Pont De Nemours And Company | Rapid assay processor |
US4602989A (en) | 1985-09-17 | 1986-07-29 | Dorr-Oliver Incorporated | Method and apparatus for determining the zeta potential of colloidal particles |
US4679439A (en) | 1985-09-17 | 1987-07-14 | Dorr-Oliver Incorporated | Method and apparatus for measuring the unsteady sedimentation potential of colloidal particles |
US4795698A (en) * | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
US4663408A (en) | 1985-12-30 | 1987-05-05 | Exxon Research And Engineering Company | Tetrapolymers of N-vinyl pyrrolidone/acrylamide/salt of acrylic acid/N-alkyl acrylamide |
US4680332A (en) | 1986-01-24 | 1987-07-14 | Xerox Corporation | Ink jet compositions and process for preparation thereof |
US5604099A (en) * | 1986-03-13 | 1997-02-18 | Hoffmann-La Roche Inc. | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
US4851331A (en) | 1986-05-16 | 1989-07-25 | Allied Corporation | Method and kit for polynucleotide assay including primer-dependant DNA polymerase |
US5114864A (en) | 1986-06-25 | 1992-05-19 | Trustees Of Tufts College | Fiber optic sensors, apparatus, and detection methods using fluid erodible controlled release polymers for delivery of reagent formulations |
US5254477A (en) | 1986-06-25 | 1993-10-19 | Trustees Of Tufts College | Flourescence intramolecular energy transfer conjugate compositions and detection methods |
US5143853A (en) | 1986-06-25 | 1992-09-01 | Trustees Of Tufts College | Absorbance modulated fluorescence detection methods and sensors |
US5252494A (en) | 1986-06-25 | 1993-10-12 | Trustees Of Tufts College | Fiber optic sensors, apparatus, and detection methods using controlled release polymers and reagent formulations held within a polymeric reaction matrix |
US4822746A (en) | 1986-06-25 | 1989-04-18 | Trustees Of Tufts College | Radiative and non-radiative energy transfer and absorbance modulated fluorescence detection methods and sensors |
CA1340806C (en) | 1986-07-02 | 1999-11-02 | James Merrill Prober | Method, system and reagents for dna sequencing |
US4791310A (en) | 1986-10-02 | 1988-12-13 | Syracuse University | Fluorescence microscopy |
US5015452A (en) | 1986-11-17 | 1991-05-14 | Clarkson University | Process for synthesis of uniform colloidal particles of rare earth oxides |
US4891324A (en) * | 1987-01-07 | 1990-01-02 | Syntex (U.S.A.) Inc. | Particle with luminescer for assays |
US5132097A (en) | 1987-02-11 | 1992-07-21 | G.D. Research | Apparatus for analysis of specific binding complexes |
US4911806A (en) * | 1987-02-27 | 1990-03-27 | Biotronics | Method and apparatus for separating particles in liquid suspension utilizing oscillating electric and magnetic fields |
US5155044A (en) | 1987-03-13 | 1992-10-13 | Coulter Electronics, Inc. | Lysing reagent system for isolation, identification and/or analysis of leukocytes from whole blood samples |
US5241012A (en) | 1987-05-19 | 1993-08-31 | Applied Immune Sciences, Inc. | Activated and conjugated polystyrene substrate |
US5389549A (en) | 1987-05-29 | 1995-02-14 | Toa Medical Electronics Co., Ltd. | Method for classifying leukocytes and a reagent used therefor |
SE458968B (en) | 1987-06-16 | 1989-05-22 | Wallac Oy | BIOSPECIFIC ANALYTICAL PROCEDURE FOR MULTIPLE ANALYTICS WHICH DO NOT INCLUDE PARTICULAR COATING AND LABELING WITH FLUORESCING LABEL SUBSTANCES |
US5194300A (en) | 1987-07-15 | 1993-03-16 | Cheung Sau W | Methods of making fluorescent microspheres |
US5132242A (en) | 1987-07-15 | 1992-07-21 | Cheung Sau W | Fluorescent microspheres and methods of using them |
US5807755A (en) | 1987-08-06 | 1998-09-15 | Multilyte Limited | Determination of ambient concentrations of several analytes |
US5395688A (en) | 1987-10-26 | 1995-03-07 | Baxter Diagnostics Inc. | Magnetically responsive fluorescent polymer particles |
US5091206A (en) * | 1987-10-26 | 1992-02-25 | Baxter Diagnostics Inc. | Process for producing magnetically responsive polymer particles and application thereof |
US6013531A (en) * | 1987-10-26 | 2000-01-11 | Dade International Inc. | Method to use fluorescent magnetic polymer particles as markers in an immunoassay |
US4832814A (en) | 1987-12-28 | 1989-05-23 | E. I. Du Pont De Nemours And Company | Electrofusion cell and method of making the same |
JPH0694483B2 (en) * | 1988-01-29 | 1994-11-24 | 三田工業株式会社 | Method for producing monodisperse polymer particles with increased particle size |
US4920056A (en) | 1988-02-19 | 1990-04-24 | The Dow Chemical Company | Apparatus and method for automated microbatch reaction |
US4873102A (en) | 1988-03-14 | 1989-10-10 | Manchium Chang | Magnetic particles |
US5244630A (en) | 1988-04-22 | 1993-09-14 | Abbott Laboratories | Device for performing solid-phase diagnostic assay |
US5002867A (en) * | 1988-04-25 | 1991-03-26 | Macevicz Stephen C | Nucleic acid sequence determination by multiple mixed oligonucleotide probes |
US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
US5185066A (en) * | 1988-08-11 | 1993-02-09 | Helena Laboratories Corporation | Immunofixation electrophoresis control system |
US5173159A (en) | 1988-09-06 | 1992-12-22 | Bertin & Cie | Multiple electrophoresis method for the controlled migration of macromolecules through rectangular gel plates |
US6147198A (en) * | 1988-09-15 | 2000-11-14 | New York University | Methods and compositions for the manipulation and characterization of individual nucleic acid molecules |
US6150089A (en) | 1988-09-15 | 2000-11-21 | New York University | Method and characterizing polymer molecules or the like |
GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
US5266427A (en) | 1988-10-18 | 1993-11-30 | Nippondenso Co., Ltd. | Display board and method for producing the same |
US5779976A (en) | 1988-11-03 | 1998-07-14 | Igen International, Inc. | Apparatus for improved luminescence assays |
FR2638848B1 (en) | 1988-11-04 | 1993-01-22 | Chemunex Sa | METHOD OF DETECTION AND / OR DETERMINATION IN A LIQUID OR SEMI-LIQUID MEDIUM OF AT LEAST ONE ORGANIC, BIOLOGICAL OR MEDICINAL SUBSTANCE, BY AN AGGLUTINATION METHOD |
US5512439A (en) | 1988-11-21 | 1996-04-30 | Dynal As | Oligonucleotide-linked magnetic particles and uses thereof |
US5536648A (en) | 1988-12-09 | 1996-07-16 | Amrad Corporation Limited | Amplified DNA assay using a double stranded DNA binding protein |
US5856092A (en) * | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
US5234809A (en) | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
FR2645160B1 (en) | 1989-03-31 | 1992-10-02 | Rhone Poulenc Chimie | |
US6610256B2 (en) | 1989-04-05 | 2003-08-26 | Wisconsin Alumni Research Foundation | Image processing and analysis of individual nucleic acid molecules |
US5075217A (en) | 1989-04-21 | 1991-12-24 | Marshfield Clinic | Length polymorphisms in (dC-dA)n ·(dG-dT)n sequences |
US6551784B2 (en) | 1989-06-07 | 2003-04-22 | Affymetrix Inc | Method of comparing nucleic acid sequences |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5698271A (en) | 1989-08-22 | 1997-12-16 | Immunivest Corporation | Methods for the manufacture of magnetically responsive particles |
GB8920571D0 (en) | 1989-09-12 | 1989-10-25 | Carr Robert J G | Examination of objects of macromolecular size |
US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
US5736349A (en) | 1989-09-29 | 1998-04-07 | Nippon Paint Co., Ltd. | Magnetic particle and immunoassay using the same |
ATE106566T1 (en) | 1989-11-21 | 1994-06-15 | Bayer Ag | OPTICAL BIOSENSOR. |
US5523231A (en) | 1990-02-13 | 1996-06-04 | Amersham International Plc | Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
US6013431A (en) | 1990-02-16 | 2000-01-11 | Molecular Tool, Inc. | Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators |
US5189549A (en) | 1990-02-26 | 1993-02-23 | Molecular Displays, Inc. | Electrochromic, electroluminescent and electrochemiluminescent displays |
US5126239A (en) | 1990-03-14 | 1992-06-30 | E. I. Du Pont De Nemours And Company | Process for detecting polymorphisms on the basis of nucleotide differences |
US5326692B1 (en) | 1992-05-13 | 1996-04-30 | Molecular Probes Inc | Fluorescent microparticles with controllable enhanced stokes shift |
US5723218A (en) | 1990-04-16 | 1998-03-03 | Molecular Probes, Inc. | Dipyrrometheneboron difluoride labeled flourescent microparticles |
EP0745689A3 (en) | 1990-05-11 | 1996-12-11 | Microprobe Corporation | A dipstick for a nucleic acid hybridization assay |
US5147777A (en) | 1990-06-18 | 1992-09-15 | Eastman Kodak Company | Biologically active reagents prepared from carboxy-containing polymer, analytical element and methods of use |
US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
US5281370A (en) * | 1990-08-22 | 1994-01-25 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of making solid crystalline narrow band radiation filter |
DE4026978A1 (en) | 1990-08-25 | 1992-02-27 | Bayer Ag | Coated substrates for electro=optical applications, etc. |
US5266497A (en) | 1990-08-31 | 1993-11-30 | Japan Synthetic Rubber Co., Ltd. | Immunochromatographic assay with improved colored latex |
US6149789A (en) | 1990-10-31 | 2000-11-21 | Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung E.V. | Process for manipulating microscopic, dielectric particles and a device therefor |
DE4035714A1 (en) | 1990-11-09 | 1992-05-27 | Fraunhofer Ges Forschung | Dipole moment and/or concn. measurement - by capacitive measurement of dielectric constant in presence of charge carrier |
WO1992008808A1 (en) | 1990-11-14 | 1992-05-29 | Siska Diagnostics, Inc. | Non-isotopic detection of nucleic acids using a polystyrene support-based sandwich hybridization assay and compositions useful therefor |
NL9002764A (en) | 1990-12-14 | 1992-07-01 | Tno | ELECTRODE, FITTED WITH A POLYMER COATING WITH A REDOX ENZYM BOND TO IT. |
US5266238A (en) | 1990-12-24 | 1993-11-30 | American Cyanamid Company | Narrow band radiation filter films |
US5225900A (en) | 1990-12-31 | 1993-07-06 | Xerox Corporation | Method of storing information within a reproduction system |
US5105305A (en) | 1991-01-10 | 1992-04-14 | At&T Bell Laboratories | Near-field scanning optical microscope using a fluorescent probe |
US5128006A (en) | 1991-01-23 | 1992-07-07 | At&T Bell Laboratories | Deposition of diamond films on semicondutor substrates |
US5244813A (en) | 1991-01-25 | 1993-09-14 | Trustees Of Tufts College | Fiber optic sensor, apparatus, and methods for detecting an organic analyte in a fluid or vapor sample |
US5244636A (en) | 1991-01-25 | 1993-09-14 | Trustees Of Tufts College | Imaging fiber optic array sensors, apparatus, and methods for concurrently detecting multiple analytes of interest in a fluid sample |
US5308749A (en) | 1991-01-25 | 1994-05-03 | Eastman Kodak Company | Method of preparing biologically active reagents from succinimide-containing polymers, analytical element and methods of use |
US5320814A (en) | 1991-01-25 | 1994-06-14 | Trustees Of Tufts College | Fiber optic array sensors, apparatus, and methods for concurrently visualizing and chemically detecting multiple analytes of interest in a fluid sample |
US5250264A (en) | 1991-01-25 | 1993-10-05 | Trustees Of Tufts College | Method of making imaging fiber optic sensors to concurrently detect multiple analytes of interest in a fluid sample |
US5364759B2 (en) | 1991-01-31 | 1999-07-20 | Baylor College Medicine | Dna typing with short tandem repeat polymorphisms and identification of polymorphic short tandem repeats |
US5784162A (en) | 1993-08-18 | 1998-07-21 | Applied Spectral Imaging Ltd. | Spectral bio-imaging methods for biological research, medical diagnostics and therapy |
JPH04271359A (en) * | 1991-02-27 | 1992-09-28 | Ricoh Co Ltd | Developer for dry processing |
US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
RU1794088C (en) | 1991-03-18 | 1993-02-07 | Институт Молекулярной Биологии Ан@ Ссср | Method of dna nucleotide sequence determination and a device for its realization |
JPH05226637A (en) | 1991-06-28 | 1993-09-03 | Oki Electric Ind Co Ltd | Method for aligning fine object and manufacture of bio element, method for aligning ultra fine particle, fine wiring method, and manufacture of polarizer using the aligning method |
US5187096A (en) * | 1991-08-08 | 1993-02-16 | Rensselaer Polytechnic Institute | Cell substrate electrical impedance sensor with multiple electrode array |
US5627040A (en) | 1991-08-28 | 1997-05-06 | Becton Dickinson And Company | Flow cytometric method for autoclustering cells |
US5474796A (en) | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
GB9119940D0 (en) | 1991-09-18 | 1991-10-30 | Hare Peter F J O | Polypeptide inhibitor of viral replication |
AU669489B2 (en) | 1991-09-18 | 1996-06-13 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
US5639603A (en) | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5993935A (en) | 1991-10-11 | 1999-11-30 | 3M Innovative Properties Company | Covalently reactive particles incorporated in a continous porous matrix |
WO1993008472A1 (en) | 1991-10-15 | 1993-04-29 | Multilyte Limited | Binding assay employing labelled reagent |
US6017696A (en) * | 1993-11-01 | 2000-01-25 | Nanogen, Inc. | Methods for electronic stringency control for molecular biological analysis and diagnostics |
US6048690A (en) | 1991-11-07 | 2000-04-11 | Nanogen, Inc. | Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
US5632957A (en) | 1993-11-01 | 1997-05-27 | Nanogen | Molecular biological diagnostic systems including electrodes |
US5849486A (en) | 1993-11-01 | 1998-12-15 | Nanogen, Inc. | Methods for hybridization analysis utilizing electrically controlled hybridization |
IL103674A0 (en) | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
US5652059A (en) | 1991-11-20 | 1997-07-29 | Bar Ilan University | Method for attaching microspheres to a substrate |
US5326691A (en) | 1991-11-21 | 1994-07-05 | John Hozier | Micro-libraries and methods of making and manipulating them methods for generating and analyzing micro-libraries |
US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
US5348853A (en) | 1991-12-16 | 1994-09-20 | Biotronics Corporation | Method for reducing non-specific priming in DNA amplification |
US5248772A (en) | 1992-01-29 | 1993-09-28 | Coulter Corporation | Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
US5221417A (en) | 1992-02-20 | 1993-06-22 | At&T Bell Laboratories | Conductive adhesive film techniques |
JPH07112539B2 (en) * | 1992-04-15 | 1995-12-06 | 工業技術院長 | Method and apparatus for producing fine particles |
US5667667A (en) | 1992-04-24 | 1997-09-16 | Isis Innovation Limited | Electrochemical treatment of surfaces |
US5498392A (en) | 1992-05-01 | 1996-03-12 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
US5587128A (en) | 1992-05-01 | 1996-12-24 | The Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification devices |
US5308586A (en) | 1992-05-01 | 1994-05-03 | General Atomics | Electrostatic separator using a bead bed |
GB9211176D0 (en) | 1992-05-27 | 1992-07-08 | Central Blood Lab Authority | Assay |
US5981176A (en) | 1992-06-17 | 1999-11-09 | City Of Hope | Method of detecting and discriminating between nucleic acid sequences |
DE69313611T2 (en) | 1992-07-02 | 1998-01-08 | Erkki Soini | BIOS-SPECIFIC MULTIPARAMETER ANALYSIS PROCEDURE |
US5329461A (en) * | 1992-07-23 | 1994-07-12 | Acrogen, Inc. | Digital analyte detection system |
US5674698A (en) | 1992-09-14 | 1997-10-07 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
US5415835A (en) | 1992-09-16 | 1995-05-16 | University Of New Mexico | Method for fine-line interferometric lithography |
KR960003373B1 (en) | 1992-09-29 | 1996-03-09 | 후지쓰 가부시키가이샤 | Programmable logic circuit |
US5565324A (en) | 1992-10-01 | 1996-10-15 | The Trustees Of Columbia University In The City Of New York | Complex combinatorial chemical libraries encoded with tags |
US5714340A (en) * | 1992-12-22 | 1998-02-03 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassay elements having a receptor zone |
US5298741A (en) | 1993-01-13 | 1994-03-29 | Trustees Of Tufts College | Thin film fiber optic sensor array and apparatus for concurrent viewing and chemical sensing of a sample |
WO1994016105A1 (en) | 1993-01-15 | 1994-07-21 | The Public Health Research Institute Of The City Of New York, Inc. | Rna assays using rna binary probes and ribozyme ligase |
US5637508A (en) | 1993-03-26 | 1997-06-10 | Geo-Centers, Inc. | Biomolecules bound to polymer or copolymer coated catalytic inorganic particles, immunoassays using the same and kits containing the same |
US5639606A (en) | 1993-04-06 | 1997-06-17 | The University Of Rochester | Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
US5643765A (en) | 1993-04-06 | 1997-07-01 | University Of Rochester | Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
JP2842758B2 (en) | 1993-05-10 | 1999-01-06 | 株式会社日立製作所 | Automatic analyzer |
US5840485A (en) | 1993-05-27 | 1998-11-24 | Selectide Corporation | Topologically segregated, encoded solid phase libraries |
ATE366741T1 (en) | 1993-05-27 | 2007-08-15 | Aventis Pharma Inc | TOPOLOGICALLY SEPARATE, SOLID-PHASE CODING LIBRARIES |
US5528392A (en) | 1993-06-07 | 1996-06-18 | Fuji Photo Film Co., Ltd. | Image-forming apparatus having liquid crystal and photoconductive members and using the same light beam for reading and writing |
CA2123940A1 (en) | 1993-06-21 | 1994-12-22 | Philip A. Guadagno | Electrophoresis plate |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US5837501A (en) | 1993-07-09 | 1998-11-17 | Akzo Nobel N.V. | Nucleic acid quantitation by co-amplification of target with multiple internal controls |
US5648124A (en) | 1993-07-09 | 1997-07-15 | Seradyn, Inc. | Process for preparing magnetically responsive microparticles |
US6087186A (en) | 1993-07-16 | 2000-07-11 | Irori | Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
GB9315847D0 (en) | 1993-07-30 | 1993-09-15 | Isis Innovation | Tag reagent and assay method |
RU2041261C1 (en) | 1993-08-11 | 1995-08-09 | Институт молекулярной биологии им.В.А.Энгельгардта РАН | Method for manufacturing of matrix for detecting of mismatches |
US5382512A (en) * | 1993-08-23 | 1995-01-17 | Chiron Corporation | Assay device with captured particle reagent |
US6251687B1 (en) | 1993-09-24 | 2001-06-26 | Biosite Diagnostics, Inc. | Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
US5447440A (en) | 1993-10-28 | 1995-09-05 | I-Stat Corporation | Apparatus for assaying viscosity changes in fluid samples and method of conducting same |
US6319472B1 (en) | 1993-11-01 | 2001-11-20 | Nanogen, Inc. | System including functionally separated regions in electrophoretic system |
US6254827B1 (en) | 1993-11-01 | 2001-07-03 | Nanogen, Inc. | Methods for fabricating multi-component devices for molecular biological analysis and diagnostics |
US6309602B1 (en) | 1993-11-01 | 2001-10-30 | Nanogen, Inc. | Stacked, reconfigurable system for electrophoretic transport of charged materials |
US5965452A (en) | 1996-07-09 | 1999-10-12 | Nanogen, Inc. | Multiplexed active biologic array |
US6068818A (en) | 1993-11-01 | 2000-05-30 | Nanogen, Inc. | Multicomponent devices for molecular biological analysis and diagnostics |
US5610287A (en) | 1993-12-06 | 1997-03-11 | Molecular Tool, Inc. | Method for immobilizing nucleic acid molecules |
GB9326450D0 (en) | 1993-12-24 | 1994-02-23 | Multilyte Ltd | Binding assay |
US5496997A (en) | 1994-01-03 | 1996-03-05 | Pope; Edward J. A. | Sensor incorporating an optical fiber and a solid porous inorganic microsphere |
GB9401833D0 (en) | 1994-02-01 | 1994-03-30 | Isis Innovation | Method for discovering ligands |
EP0754240B1 (en) | 1994-02-07 | 2003-08-20 | Beckman Coulter, Inc. | Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis |
US6090555A (en) | 1997-12-11 | 2000-07-18 | Affymetrix, Inc. | Scanned image alignment systems and methods |
US5468649A (en) | 1994-02-15 | 1995-11-21 | Abbott Laboratories | Process for labeling acridinium to microparticles and application in an instrument |
IL108726A (en) | 1994-02-22 | 1999-12-31 | Yissum Res Dev Co | Electrobiochemical method and system for the determination of an analyte which is a member of a recognition pair in a liquid medium and electrodes therefor |
GB9404709D0 (en) | 1994-03-11 | 1994-04-27 | Multilyte Ltd | Binding assay |
US5599666A (en) | 1994-03-28 | 1997-02-04 | Promega Corporation | Allelic ladders for short tandem repeat loci |
IL109240A (en) * | 1994-04-07 | 1998-02-22 | Yeda Res & Dev | Ion exchange membranes |
US5602042A (en) * | 1994-04-14 | 1997-02-11 | Cytyc Corporation | Method and apparatus for magnetically separating biological particles from a mixture |
US5571639A (en) * | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
DE4421901A1 (en) * | 1994-06-23 | 1996-01-04 | Bayer Ag | A rapid DNA test for the detection of quinolone-resistant Staphylococcus aureus pathogens in clinical specimens |
US5763198A (en) | 1994-07-22 | 1998-06-09 | Sugen, Inc. | Screening assays for compounds |
US5512490A (en) | 1994-08-11 | 1996-04-30 | Trustees Of Tufts College | Optical sensor, optical sensing apparatus, and methods for detecting an analyte of interest using spectral recognition patterns |
US5582988A (en) | 1994-09-15 | 1996-12-10 | Johnson & Johnson Clinical Diagnostics, Inc. | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same |
US5705628A (en) | 1994-09-20 | 1998-01-06 | Whitehead Institute For Biomedical Research | DNA purification and isolation using magnetic particles |
JP2792532B2 (en) | 1994-09-30 | 1998-09-03 | 日本電気株式会社 | Semiconductor device manufacturing method and semiconductor wafer |
CA2118048C (en) | 1994-09-30 | 2003-04-08 | James W. Schumm | Multiplex amplification of short tandem repeat loci |
US5843660A (en) | 1994-09-30 | 1998-12-01 | Promega Corporation | Multiplex amplification of short tandem repeat loci |
US6103379A (en) | 1994-10-06 | 2000-08-15 | Bar-Ilan University | Process for the preparation of microspheres and microspheres made thereby |
US5846719A (en) * | 1994-10-13 | 1998-12-08 | Lynx Therapeutics, Inc. | Oligonucleotide tags for sorting and identification |
US5604097A (en) * | 1994-10-13 | 1997-02-18 | Spectragen, Inc. | Methods for sorting polynucleotides using oligonucleotide tags |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
EP1489550B1 (en) | 1994-10-25 | 2011-07-20 | United Parcel Service Of America, Inc. | Automatic electronic camera for label image capture |
US5585069A (en) * | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
GB2295152A (en) | 1994-11-18 | 1996-05-22 | Pfizer Ltd | Preparation of a library of compounds by solid-phase synthesis |
US5527710A (en) | 1994-12-02 | 1996-06-18 | Igen, Inc. | Rate measurements of biomolecular reactions using electrochemiluminescence |
US5789147A (en) | 1994-12-05 | 1998-08-04 | New York Blood Center, Inc. | Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood |
KR0158780B1 (en) | 1994-12-22 | 1998-11-16 | 가네꼬 히사시 | Method and apparatus for film formation by chemical vapor deposition |
US5567304A (en) | 1995-01-03 | 1996-10-22 | Ibm Corporation | Elimination of island formation and contact resistance problems during electroetching of blanket or patterned thin metallic layers on insulating substrate |
US5834590A (en) | 1995-02-22 | 1998-11-10 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Ingap protein involved in pancreatic islet neogenesis |
US5959098A (en) | 1996-04-17 | 1999-09-28 | Affymetrix, Inc. | Substrate preparation process |
US6207369B1 (en) | 1995-03-10 | 2001-03-27 | Meso Scale Technologies, Llc | Multi-array, multi-specific electrochemiluminescence testing |
US6066448A (en) | 1995-03-10 | 2000-05-23 | Meso Sclae Technologies, Llc. | Multi-array, multi-specific electrochemiluminescence testing |
GB9507238D0 (en) | 1995-04-07 | 1995-05-31 | Isis Innovation | Detecting dna sequence variations |
US5961923A (en) | 1995-04-25 | 1999-10-05 | Irori | Matrices with memories and uses thereof |
US5751629A (en) | 1995-04-25 | 1998-05-12 | Irori | Remotely programmable matrices with memories |
US5690894A (en) | 1995-05-23 | 1997-11-25 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
US5545531A (en) * | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
DE69632324T2 (en) | 1995-06-07 | 2005-06-16 | PerSeptive Biosystems, Inc., Framingham | PNA-DNA CHIMESES AND PNA SYNTHESES FOR THEIR PREPARATION |
EP0830594A1 (en) | 1995-06-08 | 1998-03-25 | Visible Genetics Inc. | Nanofabricated separation matrix for analysis of biopolymers and methods of making and using same |
US5716852A (en) * | 1996-03-29 | 1998-02-10 | University Of Washington | Microfabricated diffusion-based chemical sensor |
US5728529A (en) | 1995-06-23 | 1998-03-17 | Baylor College Of Medicine | Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis |
JP2965131B2 (en) | 1995-07-07 | 1999-10-18 | 東洋紡績株式会社 | Magnetic carrier for nucleic acid binding and nucleic acid isolation method using the same |
US6515649B1 (en) * | 1995-07-20 | 2003-02-04 | E Ink Corporation | Suspended particle displays and materials for making the same |
DE19528029B4 (en) * | 1995-07-31 | 2008-01-10 | Chemagen Biopolymer-Technologie Aktiengesellschaft | Magnetic polymer particles based on polyvinyl alcohol, process for their preparation and use |
US6107462A (en) | 1995-08-17 | 2000-08-22 | The Regents Of The University Of California | Genes and proteins controlling cholesterol synthesis |
US5660990A (en) | 1995-08-18 | 1997-08-26 | Immunivest Corporation | Surface immobilization of magnetically collected materials |
US6200737B1 (en) | 1995-08-24 | 2001-03-13 | Trustees Of Tufts College | Photodeposition method for fabricating a three-dimensional, patterned polymer microstructure |
US5633724A (en) | 1995-08-29 | 1997-05-27 | Hewlett-Packard Company | Evanescent scanning of biochemical array |
US5994066A (en) | 1995-09-11 | 1999-11-30 | Infectio Diagnostic, Inc. | Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
US5981180A (en) | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
US5866331A (en) * | 1995-10-20 | 1999-02-02 | University Of Massachusetts | Single molecule detection by in situ hybridization |
US5744299A (en) | 1995-11-03 | 1998-04-28 | Mcw Research Foundation | Human parainfluenza virus-1 assay |
US6015664A (en) * | 1995-11-03 | 2000-01-18 | Mcw Research Foundation | Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B |
US5722470A (en) | 1995-11-09 | 1998-03-03 | Glaxo Group Limited | Bead dispensing device and methods |
US5763175A (en) | 1995-11-17 | 1998-06-09 | Lynx Therapeutics, Inc. | Simultaneous sequencing of tagged polynucleotides |
US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
US5633972A (en) | 1995-11-29 | 1997-05-27 | Trustees Of Tufts College | Superresolution imaging fiber for subwavelength light energy generation and near-field optical microscopy |
US5814524A (en) | 1995-12-14 | 1998-09-29 | Trustees Of Tufts College | Optical sensor apparatus for far-field viewing and making optical analytical measurements at remote locations |
US6156502A (en) | 1995-12-21 | 2000-12-05 | Beattie; Kenneth Loren | Arbitrary sequence oligonucleotide fingerprinting |
US20010018514A1 (en) | 1998-07-31 | 2001-08-30 | Mcgall Glenn H. | Nucleic acid labeling compounds |
US5766963A (en) | 1996-01-26 | 1998-06-16 | Pharmacopeia, Inc. | Combination hydroxypropylamine library |
DE29601618U1 (en) | 1996-01-31 | 1996-07-04 | Invitek Gmbh | Multiple simultaneous isolation device |
US5723233A (en) | 1996-02-27 | 1998-03-03 | Lsi Logic Corporation | Optical proximity correction method and apparatus |
WO1997032226A1 (en) | 1996-02-29 | 1997-09-04 | Minnesota Mining And Manufacturing Company | Brightness enhancement film |
US6297062B1 (en) | 1996-03-07 | 2001-10-02 | Bio-Magnetics Ltd. | Separation by magnetic particles |
US5747349A (en) | 1996-03-20 | 1998-05-05 | University Of Washington | Fluorescent reporter beads for fluid analysis |
US6193866B1 (en) * | 1996-03-27 | 2001-02-27 | Curagen Corporation | Separation of charged particles by a spatially and temporally varying electric field |
US7041510B2 (en) | 1996-04-25 | 2006-05-09 | Bioarray Solutions Ltd. | System and method for programmable illumination pattern generation |
US6387707B1 (en) | 1996-04-25 | 2002-05-14 | Bioarray Solutions | Array Cytometry |
ES2288760T3 (en) | 1996-04-25 | 2008-01-16 | Bioarray Solutions Ltd. | ELECTROCINETIC ASSEMBLY CONTROLLED BY LIGHT OF PARTICLES NEXT TO SURFACES. |
US7144119B2 (en) | 1996-04-25 | 2006-12-05 | Bioarray Solutions Ltd. | System and method for programmable illumination pattern generation |
US6958245B2 (en) | 1996-04-25 | 2005-10-25 | Bioarray Solutions Ltd. | Array cytometry |
US6083699A (en) | 1996-05-01 | 2000-07-04 | Visible Genetics Inc. | Method for bi-directional sequencing of nucleic acid polymers |
US5900949A (en) | 1996-05-23 | 1999-05-04 | Hewlett-Packard Company | CCD imager for confocal scanning microscopy |
JP3445455B2 (en) * | 1996-05-24 | 2003-09-08 | ペンタックス株式会社 | Image recording device |
EP0912761A4 (en) * | 1996-05-29 | 2004-06-09 | Cornell Res Foundation Inc | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
US5989835A (en) | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
NZ333346A (en) | 1996-06-28 | 2000-03-27 | Caliper Techn Corp | High-throughput screening assay systems in microscale fluidic devices |
US6075905A (en) | 1996-07-17 | 2000-06-13 | Sarnoff Corporation | Method and apparatus for mosaic image construction |
US6312134B1 (en) | 1996-07-25 | 2001-11-06 | Anvik Corporation | Seamless, maskless lithography system using spatial light modulator |
GB9615775D0 (en) | 1996-07-26 | 1996-09-04 | British Tech Group | Apparatus and method for characterising particles using dielectrophoresis |
US6506564B1 (en) * | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
BR9706597A (en) * | 1996-08-01 | 1999-07-20 | Loctite Ireland Ltd | Process for forming a monolayer of particles and products formed in this way |
AU709730B2 (en) | 1996-08-02 | 1999-09-02 | Dionex Corporation | Electromigration injection from a microreservoir-electrode in capillary separation systems |
US5831046A (en) | 1996-08-05 | 1998-11-03 | Prolinx, Incorporated | Boronic acid-contaning nucleic acid monomers |
US5792430A (en) | 1996-08-12 | 1998-08-11 | Monsanto Company | Solid phase organic synthesis device with pressure-regulated manifold |
US6203993B1 (en) | 1996-08-14 | 2001-03-20 | Exact Science Corp. | Methods for the detection of nucleic acids |
DE19633997C1 (en) | 1996-08-23 | 1998-03-26 | Univ Stuttgart | Remote image inspection facility for image transmission |
US5766711A (en) | 1996-08-29 | 1998-06-16 | Barmakian; Andrew | Composite camel structure and method for manufacture |
US6120666A (en) | 1996-09-26 | 2000-09-19 | Ut-Battelle, Llc | Microfabricated device and method for multiplexed electrokinetic focusing of fluid streams and a transport cytometry method using same |
US6124092A (en) | 1996-10-04 | 2000-09-26 | The Perkin-Elmer Corporation | Multiplex polynucleotide capture methods and compositions |
US6209589B1 (en) | 1996-10-21 | 2001-04-03 | Smithkline Beecham Plc | Apparatus and method for distributing beads |
US5786219A (en) | 1996-10-28 | 1998-07-28 | Molecular Probes, Inc. | Microspheres with fluorescent spherical zones |
US6018350A (en) * | 1996-10-29 | 2000-01-25 | Real 3D, Inc. | Illumination and shadow simulation in a computer graphics/imaging system |
US6133436A (en) | 1996-11-06 | 2000-10-17 | Sequenom, Inc. | Beads bound to a solid support and to nucleic acids |
US20020031841A1 (en) | 1996-11-06 | 2002-03-14 | Asher Sanford A. | Colorimetric reagent |
US5900481A (en) | 1996-11-06 | 1999-05-04 | Sequenom, Inc. | Bead linkers for immobilizing nucleic acids to solid supports |
US5965235A (en) | 1996-11-08 | 1999-10-12 | The Procter & Gamble Co. | Three-dimensional, amorphous-patterned, nesting-resistant sheet materials and method and apparatus for making same |
US5776711A (en) | 1996-11-12 | 1998-07-07 | The Regents Of The University Of California | Simultaneous human ABO and RH(D) blood typing or antibody screening by flow cytometry |
US5855753A (en) * | 1996-11-26 | 1999-01-05 | The Trustees Of Princeton University | Method for electrohydrodynamically assembling patterned colloidal structures |
CA2271717A1 (en) | 1996-12-12 | 1998-06-18 | Prolume, Ltd. | Apparatus and method for detecting and identifying infectious agents |
US5905024A (en) | 1996-12-17 | 1999-05-18 | University Of Chicago | Method for performing site-specific affinity fractionation for use in DNA sequencing |
CA2276462C (en) | 1996-12-31 | 2007-06-12 | Genometrix Incorporated | Multiplexed molecular analysis system apparatus and method |
US6025905A (en) * | 1996-12-31 | 2000-02-15 | Cognex Corporation | System for obtaining a uniform illumination reflectance image during periodic structured illumination |
US6100030A (en) | 1997-01-10 | 2000-08-08 | Pioneer Hi-Bred International, Inc. | Use of selective DNA fragment amplification products for hybridization-based genetic fingerprinting, marker assisted selection, and high-throughput screening |
US6027945A (en) * | 1997-01-21 | 2000-02-22 | Promega Corporation | Methods of isolating biological target materials using silica magnetic particles |
US5939021A (en) | 1997-01-23 | 1999-08-17 | Hansen; W. Peter | Homogeneous binding assay |
US5812272A (en) | 1997-01-30 | 1998-09-22 | Hewlett-Packard Company | Apparatus and method with tiled light source array for integrated assay sensing |
JP3630906B2 (en) | 1997-02-18 | 2005-03-23 | キヤノン株式会社 | Stereoscopic image display device |
US6023540A (en) | 1997-03-14 | 2000-02-08 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
US6327410B1 (en) | 1997-03-14 | 2001-12-04 | The Trustees Of Tufts College | Target analyte sensors utilizing Microspheres |
WO1998042725A1 (en) | 1997-03-21 | 1998-10-01 | Musc Foundation For Research Development | Methods and compositions for diagnosis and treatment of breast cancer |
US6235471B1 (en) | 1997-04-04 | 2001-05-22 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
EP0979071B1 (en) * | 1997-04-30 | 2007-11-07 | Point Biomedical Corporation | Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
US6106685A (en) | 1997-05-13 | 2000-08-22 | Sarnoff Corporation | Electrode combinations for pumping fluids |
US5948627A (en) * | 1997-05-30 | 1999-09-07 | One Lambda | Immunobead flow cytometric detection of anti-HLA panel-reactive antibody |
US5876946A (en) | 1997-06-03 | 1999-03-02 | Pharmacopeia, Inc. | High-throughput assay |
DE69833758T2 (en) | 1997-06-13 | 2006-08-31 | Affymetrix, Inc. (n.d.Ges.d.Staates Delaware), Santa Clara | METHOD FOR DETECTING GENE POLYMORPHISMS AND ALLELEXPRESSION USING PROBE CHIPS |
US6060243A (en) | 1997-07-17 | 2000-05-09 | Procrea Biosciences Inc. | Primers for obtaining highly informative DNA markers |
US7099777B1 (en) * | 1997-09-05 | 2006-08-29 | Affymetrix, Inc. | Techniques for identifying confirming mapping and categorizing nucleic acids |
US6130101A (en) | 1997-09-23 | 2000-10-10 | Molecular Probes, Inc. | Sulfonated xanthene derivatives |
US6540895B1 (en) | 1997-09-23 | 2003-04-01 | California Institute Of Technology | Microfabricated cell sorter for chemical and biological materials |
US5948621A (en) | 1997-09-30 | 1999-09-07 | The United States Of America As Represented By The Secretary Of The Navy | Direct molecular patterning using a micro-stamp gel |
US7115884B1 (en) | 1997-10-06 | 2006-10-03 | Trustees Of Tufts College | Self-encoding fiber optic sensor |
US6014451A (en) * | 1997-10-17 | 2000-01-11 | Pioneer Hi-Bred International, Inc. | Remote imaging system for plant diagnosis |
US6077669A (en) | 1997-11-04 | 2000-06-20 | Becton Dickinson And Company | Kit and method for fluorescence based detection assay |
US5922617A (en) | 1997-11-12 | 1999-07-13 | Functional Genetics, Inc. | Rapid screening assay methods and devices |
CA2260991C (en) | 1997-11-18 | 2009-03-24 | Bio-Rad Laboratories, Inc. | Multiplex flow immunoassays with magnetic particles as solid phase |
US6013449A (en) * | 1997-11-26 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Probe-based analysis of heterozygous mutations using two-color labelling |
US6232066B1 (en) | 1997-12-19 | 2001-05-15 | Neogen, Inc. | High throughput assay system |
AU2322099A (en) | 1998-01-16 | 1999-08-02 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
US6200814B1 (en) | 1998-01-20 | 2001-03-13 | Biacore Ab | Method and device for laminar flow on a sensing surface |
US6167910B1 (en) * | 1998-01-20 | 2001-01-02 | Caliper Technologies Corp. | Multi-layer microfluidic devices |
ATE239801T1 (en) | 1998-01-22 | 2003-05-15 | Luminex Corp | MICROPARTICLES WITH MULTIPLE FLUORESCENCE SIGNALS |
US6123263A (en) | 1998-01-29 | 2000-09-26 | Meta Holdings Corporation | Hand held dataform reader having strobing ultraviolet light illumination assembly for reading fluorescent dataforms |
US6238863B1 (en) | 1998-02-04 | 2001-05-29 | Promega Corporation | Materials and methods for indentifying and analyzing intermediate tandem repeat DNA markers |
CA2318880C (en) | 1998-02-04 | 2010-07-27 | Perkin-Elmer Corporation | Determination of a genotype of an amplification product at multiple allelic sites |
US5994079A (en) | 1998-02-06 | 1999-11-30 | Digene Corporation | Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function |
US6349144B1 (en) * | 1998-02-07 | 2002-02-19 | Biodiscovery, Inc. | Automated DNA array segmentation and analysis |
US6122599A (en) | 1998-02-13 | 2000-09-19 | Mehta; Shailesh | Apparatus and method for analyzing particles |
US6096368A (en) | 1998-02-19 | 2000-08-01 | Delsys Pharmaceutical Corporation | Bead transporter chucks using repulsive field guidance and method |
GB9803684D0 (en) | 1998-02-24 | 1998-04-15 | Genevac Ltd | Method and apparatus for controlling temperature during evaporation of samples |
US6318970B1 (en) | 1998-03-12 | 2001-11-20 | Micralyne Inc. | Fluidic devices |
US5988432A (en) | 1998-03-25 | 1999-11-23 | Sarnoff Corporation | Bead manipulating chucks with bead size selector |
DE19815129A1 (en) | 1998-04-03 | 1999-10-07 | Basf Ag | Precipitated, water-insoluble dyes in colloidally dispersed form |
US6022716A (en) | 1998-04-10 | 2000-02-08 | Genset Sa | High throughput DNA sequencing vector |
US5952131A (en) | 1998-04-27 | 1999-09-14 | Xerox Corporation | Core and shell matrix compositions and processes |
US6355419B1 (en) | 1998-04-27 | 2002-03-12 | Hyseq, Inc. | Preparation of pools of nucleic acids based on representation in a sample |
US20030087228A1 (en) | 1998-05-06 | 2003-05-08 | Cynthia Bamdad | Electronic detection of nucleic acids using monolayers |
US6251592B1 (en) | 1998-05-26 | 2001-06-26 | Procrea Biosciences Inc. | STR marker system for DNA fingerprinting |
US6139831A (en) | 1998-05-28 | 2000-10-31 | The Rockfeller University | Apparatus and method for immobilizing molecules onto a substrate |
US6699659B2 (en) | 1998-06-01 | 2004-03-02 | Affymetrix, Inc. | Products and methods for analyzing nucleic acids including identification of substitutions, insertions and deletions |
US6251595B1 (en) | 1998-06-18 | 2001-06-26 | Agilent Technologies, Inc. | Methods and devices for carrying out chemical reactions |
US6290839B1 (en) | 1998-06-23 | 2001-09-18 | Clinical Micro Sensors, Inc. | Systems for electrophoretic transport and detection of analytes |
EP1090293B2 (en) | 1998-06-24 | 2019-01-23 | Illumina, Inc. | Decoding of array sensors with microspheres |
WO2000001850A2 (en) | 1998-07-02 | 2000-01-13 | Gen-Probe Incorporated | Molecular torches |
US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US5998175A (en) | 1998-07-24 | 1999-12-07 | Lumigen, Inc. | Methods of synthesizing and amplifying polynucleotides by ligation of multiple oligomers |
DE69800630T2 (en) | 1998-07-29 | 2001-08-23 | Agilent Technologies Inc | Chip for electrophoretic separation of molecules and method for using the same |
US6132685A (en) | 1998-08-10 | 2000-10-17 | Caliper Technologies Corporation | High throughput microfluidic systems and methods |
US6126731A (en) | 1998-08-21 | 2000-10-03 | Idea Development Company | Polymerizable ink composition |
US6306643B1 (en) | 1998-08-24 | 2001-10-23 | Affymetrix, Inc. | Methods of using an array of pooled probes in genetic analysis |
US6136468A (en) | 1998-08-25 | 2000-10-24 | Timer Technologies, Llc | Electrochemical cell with deferred assembly |
JP3829491B2 (en) * | 1998-08-27 | 2006-10-04 | 株式会社日立製作所 | Probe tip, probe tip creation method, sample detection method, and sample detection device |
WO2000013018A2 (en) | 1998-08-28 | 2000-03-09 | Febit Ferrarius Biotechnology Gmbh | Support for a method for determining analytes and a method for producing the support |
US6642062B2 (en) | 1998-09-03 | 2003-11-04 | Trellis Bioinformatics, Inc. | Multihued labels |
US6136171A (en) | 1998-09-18 | 2000-10-24 | The University Of Utah Research Foundation | Micromachined electrical field-flow fractionation system |
US6480791B1 (en) | 1998-10-28 | 2002-11-12 | Michael P. Strathmann | Parallel methods for genomic analysis |
US6187540B1 (en) * | 1998-11-09 | 2001-02-13 | Identigene, Inc. | Method of newborn identification and tracking |
US20030012699A1 (en) * | 1998-11-18 | 2003-01-16 | Thomas Moore | Simultaneous handling of magnetic beads in a two-dimensional arrangement |
US6271856B1 (en) | 1998-11-19 | 2001-08-07 | Paraform, Inc. | Creating and modifying parameterizations of surfaces |
US6872546B1 (en) | 1998-12-23 | 2005-03-29 | Human Genome Sciences, Inc. | Hyaluronan-binding proteins and encoding genes |
US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
US6534293B1 (en) | 1999-01-06 | 2003-03-18 | Cornell Research Foundation, Inc. | Accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing |
EP1151139A2 (en) | 1999-01-25 | 2001-11-07 | UT-Battelle, LLC | Multifunctional and multispectral biosensor devices and methods of use |
JP3756007B2 (en) | 1999-01-28 | 2006-03-15 | 富士写真フイルム株式会社 | Dry analysis method and dry analysis element |
US20020150909A1 (en) | 1999-02-09 | 2002-10-17 | Stuelpnagel John R. | Automated information processing in randomly ordered arrays |
US6294063B1 (en) | 1999-02-12 | 2001-09-25 | Board Of Regents, The University Of Texas System | Method and apparatus for programmable fluidic processing |
US6153389A (en) | 1999-02-22 | 2000-11-28 | Haarer; Brian K. | DNA additives as a mechanism for unambiguously marking biological samples |
CN1185492C (en) * | 1999-03-15 | 2005-01-19 | 清华大学 | Single-point strobed micro electromagnetic units array chip or electromagnetic biologic chip and application thereof |
US6403309B1 (en) | 1999-03-19 | 2002-06-11 | Valigen (Us), Inc. | Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays |
AU778438B2 (en) | 1999-04-06 | 2004-12-02 | Yale University | Fixed address analysis of sequence tags |
US6908737B2 (en) * | 1999-04-15 | 2005-06-21 | Vitra Bioscience, Inc. | Systems and methods of conducting multiplexed experiments |
US6355431B1 (en) | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
US6858403B2 (en) * | 1999-05-11 | 2005-02-22 | M-Biotech, Inc. | Polymer matrix containing catalase co-immobilized with analytic enzyme that generates hydrogen peroxide |
IT1309430B1 (en) | 1999-05-18 | 2002-01-23 | Guerrieri Roberto | METHOD AND APPARATUS FOR HANDLING PARTICLES BY MEANS OF ELECTROPHORESIS |
EP1190100B1 (en) | 1999-05-20 | 2012-07-25 | Illumina, Inc. | Combinatorial decoding of random nucleic acid arrays |
US6132997A (en) | 1999-05-28 | 2000-10-17 | Agilent Technologies | Method for linear mRNA amplification |
CA2309528C (en) | 1999-06-08 | 2007-10-09 | Ortho-Clinical Diagnostics, Inc. | Simultaneous determination of forward and reverse abo blood group |
US6303316B1 (en) | 1999-07-02 | 2001-10-16 | Conceptual Mind Works, Inc. | Organic semiconductor recognition complex and system |
AU5785400A (en) * | 1999-07-02 | 2001-01-22 | Symyx Technologies, Inc. | Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded thereto |
US6268219B1 (en) | 1999-07-09 | 2001-07-31 | Orchid Biosciences, Inc. | Method and apparatus for distributing fluid in a microfluidic device |
KR100677860B1 (en) | 1999-07-23 | 2007-02-05 | 보드 오브 트러스티스 오브 유니버스티 오브 일리노이즈 | Microfabricated Devices and Method of Manufacturing The Same |
US6713309B1 (en) | 1999-07-30 | 2004-03-30 | Large Scale Proteomics Corporation | Microarrays and their manufacture |
US20020015952A1 (en) * | 1999-07-30 | 2002-02-07 | Anderson Norman G. | Microarrays and their manufacture by slicing |
DE60040603D1 (en) * | 1999-08-17 | 2008-12-04 | Luminex Corp | METHOD FOR ANALYZING A MULTIPLE OF SAMPLES OF VARIOUS ORIGIN ON AN ANALYTE |
AU2246601A (en) | 1999-08-30 | 2001-04-10 | Illumina, Inc. | Methods for improving signal detection from an array |
US6319674B1 (en) | 1999-09-16 | 2001-11-20 | Agilent Technologies, Inc. | Methods for attaching substances to surfaces |
US7225082B1 (en) | 1999-10-01 | 2007-05-29 | Oxonica, Inc. | Colloidal rod particles as nanobar codes |
AU1495101A (en) | 1999-10-01 | 2001-05-10 | Surromed, Inc. | Method of manufacture of colloidal rod particles as nanobar codes |
US6287778B1 (en) | 1999-10-19 | 2001-09-11 | Affymetrix, Inc. | Allele detection using primer extension with sequence-coded identity tags |
US6844156B2 (en) * | 1999-10-19 | 2005-01-18 | The United States Of America As Represented By The Department Of Veterans Affairs | Methods for identifying a preferred liver transplant donor |
US6077674A (en) | 1999-10-27 | 2000-06-20 | Agilent Technologies Inc. | Method of producing oligonucleotide arrays with features of high purity |
US6451191B1 (en) | 1999-11-18 | 2002-09-17 | 3M Innovative Properties Company | Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same |
US6605453B2 (en) | 1999-12-01 | 2003-08-12 | The Regents Of The University Of California | Electric-field-assisted fluidic assembly of inorganic and organic materials, molecules and like small things including living cells |
US6361916B1 (en) | 1999-12-14 | 2002-03-26 | Eastman Kodak Company | Loaded latex compositions with dye and stabilizer |
US20020007122A1 (en) | 1999-12-15 | 2002-01-17 | Howard Kaufman | Methods of diagnosing disease |
US6500620B2 (en) | 1999-12-29 | 2002-12-31 | Mergen Ltd. | Methods for amplifying and detecting multiple polynucleotides on a solid phase support |
EP1252196B1 (en) | 2000-01-05 | 2005-11-02 | Novartis AG | Hydrogels |
ATE354334T1 (en) * | 2000-02-02 | 2007-03-15 | Procter & Gamble | FLEXIBLE MANUFACTURING SYSTEM |
EP1990428B1 (en) | 2000-02-07 | 2010-12-22 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
EP1255865B1 (en) | 2000-02-07 | 2007-04-18 | Illumina, Inc. | Nucleic acid detection method using universal priming |
AU2001239760B2 (en) | 2000-02-10 | 2005-11-24 | Illumina, Inc. | Array of individual arrays as substrate for bead-based simultaneous processing of samples and manufacturing method therefor |
US7003144B2 (en) * | 2000-02-11 | 2006-02-21 | The United States Of America As Represented By The Department Of Health And Human Services | Vessel delineation in magnetic resonance angiographic images |
EP1130113A1 (en) | 2000-02-15 | 2001-09-05 | Johannes Petrus Schouten | Multiplex ligation dependent amplification assay |
US6993156B1 (en) * | 2000-02-18 | 2006-01-31 | Microsoft Corporation | System and method for statistically comparing and matching plural sets of digital data |
EP1238361A1 (en) | 2000-03-01 | 2002-09-11 | Gambro, Inc. | Extracorporeal blood processing information management system |
US20030154108A1 (en) | 2000-03-01 | 2003-08-14 | Gambro, Inc. | Extracorporeal blood processing information management system |
US6358387B1 (en) | 2000-03-27 | 2002-03-19 | Caliper Technologies Corporation | Ultra high throughput microfluidic analytical systems and methods |
AU4989501A (en) | 2000-04-06 | 2001-10-23 | Luminex Corp | Magnetically-responsive microspheres |
US7682837B2 (en) | 2000-05-05 | 2010-03-23 | Board Of Trustees Of Leland Stanford Junior University | Devices and methods to form a randomly ordered array of magnetic beads and uses thereof |
EP2565826B1 (en) | 2000-05-11 | 2019-11-06 | Becton Dickinson and Company | System for indentifying clusters in scatter plots using smoothed polygons with optimal boundaries |
US20040009614A1 (en) * | 2000-05-12 | 2004-01-15 | Ahn Chong H | Magnetic bead-based arrays |
US6645432B1 (en) | 2000-05-25 | 2003-11-11 | President & Fellows Of Harvard College | Microfluidic systems including three-dimensionally arrayed channel networks |
ES2259666T3 (en) | 2000-06-21 | 2006-10-16 | Bioarray Solutions Ltd | MOLECULAR ANALYSIS OF MULTIPLE ANALYTICS USING SERIES OF RANDOM PARTICLES WITH APPLICATION SPECIFICITY. |
JP4233238B2 (en) | 2000-07-06 | 2009-03-04 | 富士フイルム株式会社 | Colored fine particle dispersion for ink, ink for ink jet recording using the same, and ink jet recording method |
DE10042023C2 (en) * | 2000-08-08 | 2003-04-10 | Biognostic Ag | Capsules that encapsulate solid particles of signal-generating substances and their use in bioassays for the detection of target molecules in a sample |
US6824981B2 (en) * | 2000-08-11 | 2004-11-30 | Agilix Corporation | Ultra-sensitive detection systems using alterable peptide tags |
US20020182609A1 (en) | 2000-08-16 | 2002-12-05 | Luminex Corporation | Microsphere based oligonucleotide ligation assays, kits, and methods of use, including high-throughput genotyping |
EP1337670A4 (en) | 2000-08-16 | 2004-07-14 | Whatman Inc | Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies |
US7998746B2 (en) * | 2000-08-24 | 2011-08-16 | Robert Otillar | Systems and methods for localizing and analyzing samples on a bio-sensor chip |
US6713257B2 (en) | 2000-08-25 | 2004-03-30 | Rosetta Inpharmatics Llc | Gene discovery using microarrays |
US6521747B2 (en) * | 2000-08-28 | 2003-02-18 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the AGTR1 gene |
US7057704B2 (en) | 2000-09-17 | 2006-06-06 | Bioarray Solutions Ltd. | System and method for programmable illumination pattern generation |
US6498863B1 (en) | 2000-09-20 | 2002-12-24 | Media Cybernetics Inc. | Method, system, and product for analyzing a digitized image of an array to create an image of a grid overlay |
WO2002031501A1 (en) | 2000-10-12 | 2002-04-18 | Amnis Corporation | Methods for synthesizing reporter labeled beads |
US20030045005A1 (en) | 2000-10-17 | 2003-03-06 | Michael Seul | Light-controlled electrokinetic assembly of particles near surfaces |
US7130458B2 (en) * | 2000-10-24 | 2006-10-31 | Affymetrix, Inc. | Computer software system, method, and product for scanned image alignment |
US6528264B1 (en) | 2000-11-01 | 2003-03-04 | Corning Incorporated | Polymer support for DNA immobilization |
AU2001213911A1 (en) | 2000-11-02 | 2002-05-15 | Jandratek Gmbh | Surfaces comprising a hydrophilic spacer, covalently bonded to hydrogels |
US20020137074A1 (en) | 2000-11-21 | 2002-09-26 | Piunno Paul A.E. | Selectivity of nucleic acid diagnostic and microarray technologies by control of interfacial nucleic acid film chemistry |
FR2817266B1 (en) | 2000-11-29 | 2004-01-16 | Commissariat Energie Atomique | MICRO STATIC NETWORK OF BIOLOGICAL OR CHEMICAL PROBES, IMMOBILIZED ON A MAGNETIC ATTRACTION SUPPORT |
US6905881B2 (en) | 2000-11-30 | 2005-06-14 | Paul Sammak | Microbead-based test plates and test methods for fluorescence imaging systems |
US7015047B2 (en) * | 2001-01-26 | 2006-03-21 | Aviva Biosciences Corporation | Microdevices having a preferential axis of magnetization and uses thereof |
US6681788B2 (en) | 2001-01-29 | 2004-01-27 | Caliper Technologies Corp. | Non-mechanical valves for fluidic systems |
US7407746B2 (en) | 2001-02-08 | 2008-08-05 | Ngk Insulators, Ltd. | Biochip and method for producing the same |
AU2002252297A1 (en) | 2001-03-10 | 2002-09-24 | Bioinformatics Dna Codes, Llc | Methods and tools for nucleic acid sequence analysis selection and generation |
US6706163B2 (en) | 2001-03-21 | 2004-03-16 | Michael Seul | On-chip analysis of particles and fractionation of particle mixtures using light-controlled electrokinetic assembly of particles near surfaces |
EP1379693B1 (en) | 2001-03-28 | 2009-05-20 | Nanosphere, Inc. | Bio-barcodes based on oligonucleotide-modified particles |
US20020142318A1 (en) | 2001-03-30 | 2002-10-03 | Cattell Herbert F. | Chemical array reading |
GB0110053D0 (en) | 2001-04-24 | 2001-06-13 | Axis Shield Asa | Assay |
JP3761418B2 (en) | 2001-05-10 | 2006-03-29 | Hoya株式会社 | Compound crystal and process for producing the same |
US6689478B2 (en) * | 2001-06-21 | 2004-02-10 | Corning Incorporated | Polyanion/polycation multilayer film for DNA immobilization |
US7262063B2 (en) | 2001-06-21 | 2007-08-28 | Bio Array Solutions, Ltd. | Directed assembly of functional heterostructures |
US7172804B2 (en) | 2001-07-17 | 2007-02-06 | Northwestern University | Film-immobilized capture particles |
US7285412B2 (en) * | 2001-07-27 | 2007-10-23 | Surface Logix Inc. | Device for magnetic immobilization of cells |
US20030040129A1 (en) * | 2001-08-20 | 2003-02-27 | Shah Haresh P. | Binding assays using magnetically immobilized arrays |
US6503680B1 (en) * | 2001-08-29 | 2003-01-07 | Xerox Corporation | Latex processes |
US20030062422A1 (en) | 2001-09-10 | 2003-04-03 | Fateley William G. | System and method for encoded spatio-spectral information processing |
US7195913B2 (en) | 2001-10-05 | 2007-03-27 | Surmodics, Inc. | Randomly ordered arrays and methods of making and using |
WO2003031591A2 (en) | 2001-10-10 | 2003-04-17 | Superarray Bioscience Corporation | Detecting targets by unique identifier nucleotide tags |
EP2722395B1 (en) * | 2001-10-15 | 2018-12-19 | Bioarray Solutions Ltd | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
US6927018B2 (en) | 2001-10-29 | 2005-08-09 | Hewlett-Packard Development Company, L.P. | Three dimensional printing using photo-activated building materials |
WO2003038558A2 (en) | 2001-10-30 | 2003-05-08 | Nanomics Biosystems Pty, Ltd. | Device and methods for directed synthesis of chemical libraries |
US6838289B2 (en) * | 2001-11-14 | 2005-01-04 | Beckman Coulter, Inc. | Analyte detection system |
US6792355B2 (en) | 2001-12-21 | 2004-09-14 | Triad Therapeutics, Inc. | Methods for determining polypeptide structure, function or pharmacophore from comparison of polypeptide sequences |
US7335153B2 (en) | 2001-12-28 | 2008-02-26 | Bio Array Solutions Ltd. | Arrays of microparticles and methods of preparation thereof |
DE10164309A1 (en) | 2001-12-28 | 2003-07-10 | Fraunhofer Ges Forschung | Improved structured-functional binding matrices for biomolecules |
US20030152931A1 (en) | 2002-02-11 | 2003-08-14 | Chung-Fan Chiou | Nucleic acid detection device and method utilizing the same |
JP2003263507A (en) | 2002-03-12 | 2003-09-19 | Nippon Colin Co Ltd | Method and device for providing statistical medical information |
US20030186220A1 (en) | 2002-03-28 | 2003-10-02 | Jizhong Zhou | Detecting microorganisms using whole genomic DNA or RNA microarray |
US6730515B2 (en) | 2002-06-11 | 2004-05-04 | Eastman Kodak Company | Micro-array calibration means |
US7041453B2 (en) | 2002-08-22 | 2006-05-09 | Bioarray Solutions Ltd. | Molecular constructs and methods of use for detection of biochemical reactions |
US7157228B2 (en) | 2002-09-09 | 2007-01-02 | Bioarray Solutions Ltd. | Genetic analysis and authentication |
US7401028B2 (en) | 2002-11-08 | 2008-07-15 | Deakter Daniel R | System and process for matching patients with clinical medical trials |
WO2004047007A1 (en) | 2002-11-15 | 2004-06-03 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
US7141217B2 (en) | 2002-12-05 | 2006-11-28 | Uop Llc | Elevated pressure apparatus and method for generating a plurality of isolated effluents |
US6869798B2 (en) | 2003-04-17 | 2005-03-22 | Clinical Diagnostics Solutions, Inc. | Lytic reagent composition for leukocyte differential analysis |
US20040229269A1 (en) * | 2003-05-15 | 2004-11-18 | Ghazala Hashmi | Hybridization-mediated analysis of polymorphisms |
ES2375962T3 (en) | 2003-09-22 | 2012-03-07 | Bioarray Solutions Ltd | IMMOBILIZED SURFACE POLYELECTROLYTE WITH MULTIPLE FUNCTIONAL GROUPS ABLE TO JOIN COVALENTLY TO BIOMOLECULES. |
WO2005033895A2 (en) | 2003-10-03 | 2005-04-14 | Cira Discovery Sciences, Inc. | Method and apparatus for discovering patterns in binary or categorical data |
WO2005043117A2 (en) | 2003-10-28 | 2005-05-12 | Bioarray Solutions Ltd. | Gel-shell beads with adsorbed or bound biomolecules |
EP1692298A4 (en) * | 2003-10-28 | 2008-08-13 | Bioarray Solutions Ltd | Optimization of gene expression analysis using immobilized capture probes |
ES2533876T3 (en) | 2003-10-29 | 2015-04-15 | Bioarray Solutions Ltd | Multiplexed nucleic acid analysis by double stranded DNA fragmentation |
US20050112585A1 (en) | 2003-11-21 | 2005-05-26 | Dominic Zichi | Method for adjusting the quantification range of individual analytes in a multiplexed assay |
US20080261205A1 (en) | 2004-02-06 | 2008-10-23 | Canadian Blood Services | Method for the Simultaneous Determination of Blood Group and Platelet Antigen Genotypes |
US20050191682A1 (en) | 2004-02-17 | 2005-09-01 | Affymetrix, Inc. | Methods for fragmenting DNA |
WO2005081908A2 (en) * | 2004-02-20 | 2005-09-09 | The Trustees Of The University Of Pennsyvania | Reagents, kits and methods for immunodetection of epitopes on molecules |
US7848889B2 (en) | 2004-08-02 | 2010-12-07 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
US7501253B2 (en) | 2004-09-21 | 2009-03-10 | The Board Of Trustees Of The Leland Stanford Junior University | DNA fingerprinting using a branch migration assay |
US8486629B2 (en) | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
NZ567403A (en) | 2005-10-07 | 2011-03-31 | Johnson & Johnson Res Pty Ltd | Multicomponent nucleic acid enzymes and methods for their use |
US20070243534A1 (en) | 2006-04-12 | 2007-10-18 | Michael Seul | Probe density considerations and elongation of self-complementary looped probes where probes are attached to a solid phase |
DE102008045650A1 (en) | 2008-09-02 | 2010-03-04 | Siemens Aktiengesellschaft | Track and busbar system in flat profile design with several sub-conductor rails with recess on the narrow side for engaging contact spring elements |
US20100062518A1 (en) | 2008-09-09 | 2010-03-11 | Sukanta Banerjee | Concentrating White Blood Cells for DNA Extraction from a Leukodepleted Blood Sample |
WO2010098765A1 (en) | 2009-02-27 | 2010-09-02 | Leslie Cifuentes French | Dispenser and applicator that bring reactive substances into contact with each other at the time of use |
-
2004
- 2004-09-17 WO PCT/US2004/030499 patent/WO2005029705A2/en active Application Filing
- 2004-09-17 US US10/943,760 patent/US7927796B2/en not_active Expired - Fee Related
-
2011
- 2011-03-24 US US13/071,055 patent/US8615367B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567627A (en) * | 1991-07-16 | 1996-10-22 | Trans-Med Biotech, Incorporated | Method and composition for the simultaneous and discrete analysis of multiple analytes |
Also Published As
Publication number | Publication date |
---|---|
US7927796B2 (en) | 2011-04-19 |
US20050288870A1 (en) | 2005-12-29 |
US20110184655A1 (en) | 2011-07-28 |
WO2005029705A3 (en) | 2005-09-01 |
US8615367B2 (en) | 2013-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Leslie et al. | A statistical method for predicting classical HLA alleles from SNP data | |
US20040049354A1 (en) | Method, system and computer software providing a genomic web portal for functional analysis of alternative splice variants | |
CN106778073B (en) | A kind of method and system of assessment tumor load variation | |
EP3583214A1 (en) | Methods and compositions for identifying or quantifying targets in a biological sample | |
US20180051329A1 (en) | Alignment and variant sequencing analysis pipeline | |
US7729864B2 (en) | Computer systems and methods for identifying surrogate markers | |
US20160002714A1 (en) | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification | |
WO1997014028A9 (en) | Multiplexed analysis of clinical specimens apparatus and method | |
JP2005527904A (en) | Computer system and method for subdividing complex diseases into constituent diseases | |
Orzińska et al. | A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors | |
CN106460045B (en) | Common copy number variation of human genome for risk assessment of susceptibility to cancer | |
US11302417B2 (en) | Systems and methods for SNP characterization and identifying off target variants | |
WO2008152404A2 (en) | Allelic determination | |
CN113278712B (en) | Gene chip, molecular probe combination, kit and application for analyzing sheep hair color | |
Reid | Transfusion in the age of molecular diagnostics | |
CN103168118A (en) | Gene-expression profiling with reduced numbers of transcript measurements | |
Paccapelo et al. | HEA BeadChip technology in immunohematology | |
US20070093968A1 (en) | Selection of Genotyped transfusion donors by cross-matching genotyped recipients | |
US8615367B2 (en) | Number coding for identification of subtypes of coded types of solid phase carriers | |
US20050202469A1 (en) | Multiplexed analysis of clinical specimens apparatus and methods | |
WO2003072701A1 (en) | A system for analyzing dna-chips using gene ontology and a method thereof | |
US20050287575A1 (en) | System and method for improved genotype calls using microarrays | |
CN113293220B (en) | Gene chip for analyzing ear size of sheep, molecular probe combination, kit and application | |
CN114171116A (en) | Method for evaluating fetal DNA concentration by free and self DNA of pregnant woman and application | |
JPWO2004097015A1 (en) | Array in which substances immobilized on support are arranged by adding chromosome order or sequence position information, manufacturing method thereof, analysis system using array, and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NA NI NO NZ PG PH PL PT RO RU SC SD SE SG SK SY TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IT MC NL PL PT RO SE SI SK TR BF CF CG CI CM GA GN GQ GW ML MR SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |